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ABSTRACT 
 
Georgios A. Bobetsis 
 
Campylobacter rectus Infection Impairs Placental Function and 
Development in Mice 
 
(Under the direction of Steven Offenbacher) 
 
In humans, periodontal disease has been associated with an increased risk for preterm 
and low birth weight deliveries. Among the periodontal pathogens, Campylobacter rectus (C. 
rectus) appears to play a key role in these processes. Several animal models have been 
developed to study the effects of periodontal bacteria on pregnancy outcomes, and 
demonstrate their deleterious consequences on fetal growth. Since the placenta is the organ 
where nutrient exchange takes place between the mother and the fetus, and since its normal 
development is considered of crucial importance for the normal growth and development of 
the fetus, our hypothesis is that maternal infection with C. rectus impairs placental function 
and development, which may contribute to intrauterine growth restriction (IUGR). 
 We used a pregnancy/infection mouse model and found that C. rectus infection leads 
to IUGR. Moreover, the bacteria not only disseminated to the placenta, but also translocated 
to fetal tissues where they have the capacity of invading host cells. The presence of C. rectus 
in the placenta may have mediated structural changes in this organ, with the most significant 
being the decrease of the labyrinth and the increase of the decidual layer. These alterations 
could have been induced by the down-regulation in the expression of genes important for 
placental and fetal growth and development. Among these genes several imprinted genes, 
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such as Igf2, were included. Finally, we found that C. rectus infection induced 
hypermethylation of the promoter of Igf2. This may present a possible mechanism for the 
down-regulation of this gene and possibly of other imprinted genes. 
 The data from this study provide information about potential mechanisms that 
underlie the impaired fetal growth after maternal infection with the periodontal pathogen C. 
rectus. Moreover, since changes in the methylation patterns of genes are usually inherited in 
somatic cells, our data raise the possibility that infection-mediated epigenetic modifications 
of the DNA, that occur in utero, may predispose the individual for diseases that appear later 
in life. 
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Chapter 1 
 
Introduction 
2Low Birth Weight and Intrauterine Growth Restriction: Epidemiology and Definitions 
Low birth weight (LBW), defined as weight at birth of less than 2,500 g, and very 
low birth weight (VLBW), defined as weight at birth of less than 1,500 g are both adverse 
pregnancy outcomes affecting a significant percentage of the population world wide (1). 
Despite the advances in maternal prenatal care, the incidence of LBW has not decreased and 
only in the United States during the last two decades the percentage of LBW and VLBW 
infants has increased by 11.8% and 24.3% respectively (1). This has been attributed primarily 
to the fact that not all of the contributing causes are identified (2). Twenty five to 50% of 
preterm births and LBW deliveries occur without any known etiology, while some of the 
known risk factors include smoking, alcohol consumption, parity (i.e. the number of previous 
births), short cervical length, short maternal structure, low maternal weight, high physical 
and psychological stress, low socioeconomic status and education and poor maternal 
nutrition (3-5).  
Impaired growth at birth is thought to result in an increased risk of infant mortality, or 
contribute to long-term disabilities (1,6,7). Specifically, LBW babies that survive the 
neonatal period are more likely to develop neurodevelopmental problems, respiratory 
problems, congenital anomalies, behavioral problems, cardiovascular disease and metabolic 
abnormalities, such as obesity, hypercholesterolemia, impaired glucose tolerance, and type 2 
diabetes melitius (8-14).  
LBW may be caused by a shortened gestational period (i.e. preterm delivery), where 
birth occurs at less than 37 weeks of gestation, and/or by a retarded intrauterine growth. 
Intrauterine growth restriction (IUGR) refers to insufficient fetal growth for gestational age 
and has been defined as fetal weight of less than 2 standard deviations (SD) below the mean 
3fetal weight for gestational age (15). In essence, there are three classes of IUGR: a) 
idiopathic IUGR, b) IUGR resulting from maternal factors, such as preeclampsia, and c) 
IUGR of fetal/placental origin, such as chromosomal abnormalities. The etiology of the 
majority of IUGR remains unknown (16).   
In humans, IUGR can be determined indirectly by abnormal morphometric 
parameters at prenatal sonographic analysis (17). However, most studies evaluate growth 
restriction at birth (LBW), in which case, the distinction between LBW at term, and LBW 
associated with premature delivery needs to be made. On the other hand, in many 
experimental animal models practical and ethical reasons allow for a more in-depth study of 
IUGR during various stages of the gestation. Moreover, some of these animals such as mice 
do not demonstrate preterm deliveries, so LBW is commonly attributed to IUGR. Hence, 
various mouse models have been developed to better understand the mechanisms that govern 
IUGR and suggest possible mechanisms of IUGR in humans. 
Bacterial Infections and Pregnancy Complications 
Bacterial infections within the uterus can occur between the maternal tissues and the 
fetal membranes, within the fetal membranes, within the placenta, within the amniotic fluid, 
or within the umbilical cord or the fetus (Fig. 1.1) (18). Currently, there is increasing 
evidence that maternal infections during pregnancy and attendant inflammatory responses 
may play a significant role in preterm births and LBW (19). Specifically, it has been 
proposed that infection may induce pregnancy complications either by direct infection of the 
fetal/placental unit and/or indirectly by maternally produced inflammatory mediators in the 
maternal/fetal interface (20,21). This in utero fetal stress may affect the growth and 
4development of the fetus which could be reflected as a premature delivery, IUGR, LBW and 
disabilities that extend throughout the lifetime of the individual.  
 Generalized infections, such as viral respiratory infections, diarrhea or malaria, as 
well as more localized infections of the genitourinary tract can affect the duration of 
gestation (22,18,20,23). Bacterial vaginosis, a Gram negative anaerobic infection, is the 
infection most implicated with pregnancy complications, but chorioamnionitis and infection 
of the amniotic fluid have also been considered important risk factors for preterm births and 
LBW (24,25,21). Interestingly, several organisms of the oral cavity, such as capnocytophaga, 
have been found in the uterus in association with chorioamnionitis, while others,  especially 
periodontal pathogens, have been associated with immunological and inflammatory 
responses in the fetal/placental unit and are related to preterm and growth restricted births 
(26,27). 
Periodontal Infection and its Role in Pregnancy Complications 
Periodontal disease (gingivitis and periodontitis) presents a major health problem 
affecting, in various levels of severity, more than 50% of the population. In brief, periodontal 
disease is initiated when, in the absence of adequate oral hygiene, periodontal bacteria 
accumulate in the gingival crevice of teeth and form an organized structure known as 
“bacterial biofilm”. These bacteria possess a plethora of virulent factors that may cause direct 
destruction to periodontal tissues or stimulate the host to activate a local inflammatory 
response which, although intended to eliminate the infection may also lead to further loss of 
periodontal connective tissue and destruction of alveolar bone (28,29). Moreover, bacteria 
and/or their shed virulent factors may enter the blood stream and disseminate throughout the 
5body and trigger the induction of systemic inflammatory responses and/or ectopic 
infection/inflammation. 
The ability of periodontal pathogens and their virulent factors to induce local and 
systemic inflammatory responses in the host has led to the hypothesis that periodontal 
disease may have consequences beyond the periodontal tissues themselves. In fact, several 
studies suggest a significant association between maternal periodontal disease and pregnancy 
complications including premature delivery, preeclampsia, LBW and a birth weight below 
the 10th percentile (small for gestational age) (7,30-37).  
Specifically, cohort human studies have illustrated that moderate to severe 
periodontal disease is highly prevalent among pregnant women with about 15% affected 
during the first trimester and overall about 25% showing worsening periodontal progression 
during pregnancy. Both antenatal periodontal disease and progression appear to confer risk 
for preterm delivery and the strength of the association increases at earlier gestational 
deliveries (30,35,38,39). Furthermore, periodontal disease is found to be twice as prevalent 
among African Americans and it has been suggested that the difference in periodontal 
disease prevalence may, in part, explain the observed increase risk in preterm delivery and 
LBW among African Americans (26,35).  
This decrease in birth weight appears to be associated with intrauterine exposure to 
periodontal pathogens. It has been demonstrated that the highest rate of preterm and LBW 
deliveries is observed among those mothers without a protective IgG response coupled with a 
high fetal IgM response against periodontal bacteria, such as C. rectus, P. intermedia, P. 
gingivalis, e.t.c. (7,39). Moreover, from those fetuses the risk for preterm birth is greatest 
among fetuses that also demonstrate an inflammatory response as revealed by the increase in 
6cord serum levels of C-reactive protein, interleukin (IL)-1beta, IL-6, tumor necrosis factor 
(TNF)-alpha, Prostaglandin E2, and 8-isoprostane (40). These findings support the concept 
that maternal periodontal infection in the absence of a protective maternal antibody response 
is associated with systemic dissemination of oral organisms that translocate to the fetus 
resulting in prematurity and LBW. In addition, neonates who have elevated IgM antibody to 
both P. gingivalis and C. rectus are twice as likely to be admitted to the neonatal intensive 
care unit (NICU) and three times as likely to stay within the NICU for more than 7 days. 
Hence, the high prevalence of elevated fetal IgM to C. rectus among premature infants raises 
the possibility that this specific maternal oral pathogen may serve as a primary fetal 
infectious agent eliciting pregnancy complications. 
Preliminary intervention studies also suggest that improving the oral health of 
pregnant women may reduce the incidence of adverse pregnancy outcomes implying a direct 
cause-result relationship between periodontal disease and premature deliveries and LBW 
(41,42). 
Campylobacter rectus and its Role in Pregnancy Complications 
Campylobacter rectus (C. rectus), formerly known as Wolinella recta, belongs to the 
family of campylobacteriaceae, which consists of 15 species and 6 subspecies, as defined by 
rRNA sequencing (43). It is a Gram-negative, anaerobic, asaccharolytic, motile bacterium. It 
is very small in size, less than 0.45 µm in length, and has a rod-like shape.  C. rectus may 
also take coccoid forms on prolonged culture or upon exposure to oxygen, which may render 
this bacterium non-cultivable (43).  
 Several virulence factors, such as the surface-layer (S-layer), the pore-forming protein 
toxins belonging to the family of the RTX proteins, heat shock proteins (GroEL-like 
7proteins), and the flagellum have been thought to play a role in its pathogeneity (44-46). The 
S-layer is probably the most studied virulence factor and is assumed to be involved in the 
resistance of C. rectus against phagocytic uptake and bactericidal activity of serum 
complement (47,48). It is also considered to mediate adhesion with host cells (49). 
Interestingly, from the other Campylobacter species only C. fetus (a reproductive tract 
pathogen of livestock) is known to also express an S-layer (44).      
Although the Campylobacters have emerged as important human pathogens, only C. 
rectus has been associated with several forms of human periodontal diseases. Socransky and 
coworkers have divided the pathogenic facultative and anaerobic Gram negative bacteria 
present in the bacterial biofilm in microbial complexes or clusters of microorganisms and 
assigned color designations for the convenience of discussion (50). Based on this 
classification, C. rectus belongs to the organisms of the “orange” complex, which also 
includes F. nucleatum, P. micros, P. intermedia and P. nigrescence. During maturation of the 
biofilm these bacteria provide the necessary habitat for the subsequent colonization of the 
“red” complex organisms, such as P. gingivalis, T. forsythus, and T. denticola. Although the 
exact role of each individual of these species in the progression of periodontal disease is not 
fully understood, it is clear that the presence of a large group of bacteria is somehow 
necessary for the overall pathogenic effect.  
Besides periodontal disease, other infectious diseases have been associated with 
various Campylobacter species. For example C. jejuni and C. coli are among the most 
common causes of infectious diarrhea, whereas C. fetus subsp. fetus is recognized as a cause 
of septicemia in immunocompromised hosts (51,52). 
8Infections with Campylobacter species have also been implicated in the induction of 
pregnancy complications. It was in 1909 that Campylobacters  were first considered as 
causative organisms of abortion in cattle in England (53). Since then, extensive studies have 
proven Campylobacter to be a leading cause of abortion in both sheep and cattle (53). In 
humans, mainly C. fetus, but also C. jejuni and C. coli have also been associated with 
abortion, premature labor, and perinatal sepsis (52). Finally, in a mouse model intravenous 
injection of C. fetus and C. jejuni resulted in IUGR, impaired fetal development and increase 
in resorptions, whereas similar effects were present after administration of purified LPS from 
the same Campylobacter species (54,55). 
 Similarly to these Campylobacters, C. rectus has also been shown to induce 
pregnancy complications. In humans with periodontal disease, elevated levels of fetal cord 
blood IgM against C. rectus is present and associated with preterm deliveries and LBW (7). 
In addition, in a mouse model, infection of pregnant mice with C. rectus AT2233 led to 
IUGR and increase in resorptions (51). 
 The exact mechanism by which different Campylobacter species and other 
periodontal pathogens induce pregnancy complications is not fully understood. However, the 
use of animal models has proven to be a valuable source of information.  
Animal Models Used to Study the Effect of Periodontal Pathogens on Pregnancy 
Outcomes 
A number of animal models have been used to assess the effects of periodontal 
disease on fetal growth and development. In these studies the most common animals used are 
rabbits, hamsters, and mice mainly due to the large litter size and the small time of gestation. 
Periodontal pathogens are injected in the animals either intravenously or   in a subcutaneous 
9tissue chamber that has been previously implanted in the animal (subcutaneous tissue 
chamber model) (56). Most of these experimental models reveal that maternal infection with 
periodontal pathogens has a deleterious effect on fetal growth and viability. 
Specifically, intravenous maternal exposure to P. gingivalis LPS prior to and during 
pregnancy induced adverse effects on the developing fetus in Golden hamsters. Fetal 
malformation, IUGR and increase in resorptions were evident in a dose dependent manner 
(57). Using the chamber model this time and P. gingivalis bacteria instead of LPS the same 
group demonstrated that infection of Golden hamsters with this periodontal pathogen 
mediated IUGR, increase in resorptions and embryo-lethality. The severity of these adverse 
pregnancy outcomes depended upon the intra-chamber inflammatory response elicited by the 
infection (58).  
Similar results were also observed using the chamber model in pregnant mice. 
Infection with P. gingivalis strain A7436 bacteria induced IUGR, and an elevated systemic 
maternal inflammatory and immune response in dams with IUGR fetuses. This was 
demonstrated by the elevated levels of serum P. gingivalis-specific IgG, and TNF-L, and the 
decreased levels of Il-10 in dams with IUGR fetuses. Moreover, the bacteria disseminated 
from the chamber systemically and were found to be present in the maternal liver and uterus 
and also in placental tissues corresponding to IUGR fetuses. Bacterial translocation in the 
placenta was associated with a shift in the placental Th1/Th2 cytokine balance, suggesting 
alterations in the function of placentas of IUGR fetuses (59,60). Another study using the 
chamber model in rabbits confirmed the disseminating pattern of P. gingivalis and moreover 
revealed a transplacental passage of this oral pathogen to the fetus as indicated by the 
presence of P. gingivalis in the fetal liver. However, in this model P. gingivalis infection did 
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not impair fetal growth at term nor did it induce a systemic inflammatory response. This 
could have occurred either due to the very small number of animals in the study, or the lower 
level of bacteria used to infect the rabbits as compared to that used in the mouse model 
(61,62).   
The effects of maternal C. rectus challenge in pregnancy outcomes have also been 
studied in the mouse chamber model. Similarly to P. gingivalis, infection with C. rectus 
strain ATCC 33238 induced IUGR and increase in resorptions. Moreover, the bacteria could 
disseminate from the chambers to the maternal liver and the placenta of infected dams (63). 
Experiments on the same mouse model but using a different strain of C. rectus (strain 314) 
reproduced the effects of C. rectus strain ATCC 33238. Furthermore, the bacteria entered the 
fetal tissues, as demonstrated by nested PCR for C. rectus in the fetal brain of IUGR fetuses 
(unpublished data). Interestingly, translocation of bacteria in the fetal brain was concomitant 
to an elevated inflammatory response, such as the increase in the expression of Ifn-g, in these 
tissues. Furthermore, maternal C. rectus infection increased pup mortality and preliminary 
findings demonstrated ultrastructural changes in the hippocampal region of the neonatal 
brain, in a manner analogous to the effect of maternal infection on white matter damage seen 
in humans (64). These findings suggest that the threat of maternal infection with periodontal 
pathogens during pregnancy may not be limited to the duration of gestation, but may also 
potentially affect perinatal neurological growth and development. Finally, C. rectus 314 
infection downregulated the expression of placental growth factors and induced structural 
alterations in the placenta suggestive of impaired development and function of this organ.   
Placental development 
11
The placenta is a vital organ for the survival of the mammalian embryo in the uterus 
acting as the interface between the fetal and maternal environments. Its prominent function is 
in the transfer of nutrients, gases and waste products between the mother and fetus. It is 
effectively the lung, gut, and kidney of the fetus. In addition, it is involved in the production 
of growth factors important for the growth and development of the placenta and embryo, and 
of hormones that are critical for the maintenance of pregnancy and the initiation of labor. 
Finally, the placenta acts as a selective immunological barrier, so that the maternal immune 
system does not attack the fetal allograft. It is obvious that any genetic or environmental 
insult that may affect the development of the placenta at any stage could be detrimental for 
its normal function. Perturbations in one of its many functions can lead to placental 
insufficiency, IUGR and even fetal death. 
 In recent years, a broad array of mouse mutants that demonstrate placental defects has 
been developed. These mouse models have provided insights into both the molecular 
pathways required for formation of different placental substructures and the nature of 
intercellular interactions between trophoblasts, mesenchymal and vascular components that 
regulate placental development.   
 Although, there is structural diversity among the placenta of different species, the 
placenta of both humans and rodents appear to be “hemochorial”, meaning that the placental 
trophoblasts form a structure that allows them to come in direct contact with the maternal 
blood, thus permitting nutrient and waste exchange. This common feature has rendered the 
mouse a useful model to study placental development and function. 
 In mice, the mature placenta has a discoid shape and mainly fetal origin. It consists of 
three main layers, the trophoblast giant cell monolayer, which is in contact with the 
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maternally derived decidua, an underlying cell dense region called the spongiotrophoblast, 
and the labyrinth. The development of these layers has been extensively described (65-69) 
and is illustrated in Figure 1.2. In summary, at E4.5, briefly after the embedding of the 
embryo into the lining of the uterus (implantation) the different trophoblast cell types start to 
form. At E6.0 the trophectoderm cells away from the inner cell mass (ICM) which have 
stopped dividing but have continued to endoreduplicate their DNA form the trophoblast giant 
cells. These cells form a monolayer surrounding the entire conceptus. Also, by E6.0 the 
extra-embryonic ectoderm, a diploid derivative of the early post-implantation trophoblast is 
formed and will probably give rise to the labyrinth trophoblasts. At the same time the 
ectoplacental cone, which is also a diploid derivative of the early post-implantation 
trophoblast has formed and will probably develop to the spongiotrophoblasts. At E8.5 the 
allantois arises from the mesoderm at the posterior end of the embryo and makes contact with 
the chorion (chorioallantoic fusion). Hours later, the chorion creates folds that direct the 
growth of blood vessels from the allantois generating the fetal part of the placental vascular 
network. The labyrinth trophoblasts and the associated fetal blood vessels will undergo 
extensive villous branching forming a dense and well organized structure, the labyrinth. 
While the labyrinth is developing, it is supported structurally by the spongiotrophoblast cells. 
These form a layer between the labyrinth and the giant cells and play a major role in 
stripping off endothelial cells from the maternal blood vessels allowing the maternal blood to 
come in direct contact with the placental trophoblasts. Specifically, the maternal blood enters 
the uterus through radial arteries that branch into 5-10 spiral arteries. These arteries become 
dilated in the metrial triangle and as they approach the giant cells they progressively lose 
elastin and smooth muscle. Then, while still in the decidua, the spiral arteries converge 
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together and as they enter the giant cells and the spongiotrophoblast layer they no longer 
possess the typical features of a vessel. The endothelial cells are removed and the 
trophoblasts form 1-4 central arterial canals that guide the maternal blood into the fetal side 
of the labyrinth. There it bathes the dense network of labyrinth trophoblasts, and from the 
perfused sinusoids small fetal arterioles start and converge to eventually form the umbilical 
artery which brings the oxygenated and nutrient-enriched blood to the fetus. The maternal 
blood in the labyrinth will then move towards the maternal side of the labyrinth that is still 
lined by trophoblast cells. In these sinusoids fetal blood enters originating from the umbilical 
vain bringing with it waste products from the fetus. These sinusoids coalesce into larger 
channels that traverse the spongiotrophoblast and giant cell layers and lead to maternal 
endothelial cell-lined, large venous sinuses in the decidua. This allows the blood to return 
back to the maternal circulation. 
By E10.5 the placenta has a mature structure consisting of the three distinct layers 
described (trophoblast giant cell monolayer, spongiotrophoblast, and labyrinth). Moreover, 
the circulatory pattern of maternal blood through the placenta is also established. From this 
time point the placenta will grow until E16.5 where it attains its maximum volume. However, 
the labyrinth volume continues to increase at the expense of the spongiotrophoblast layer and 
the decidua. Since the labyrinth is the actual zone where nutrient exchange takes place, this 
increase in the labyrinth volume occurs in order for the placenta to compensate for the 
elevated demand for nutrients generated from the fast growing fetus (70).  
Finally, one more alteration in the mature placenta occurs around E12.5. Glycogen 
cells appear in the spongiotrophoblast layer. Although the origin and function of these cells is 
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not completely understood it is believed that they are involved in the synthesis and storage of 
glycogen which is used as energy source for the developing placenta and fetus (71). 
Genes involved in placental development and function 
As in every developing organ, placental development and function is tightly regulated 
by a wide range of genes that control the expression of transcription factors, enzymes, 
adhesion molecules, growth factors, growth factor receptors, hormones, etc. Most of these 
genes are expressed by specific cell types and in an orchestrated manner that serves their 
spatial and temporal need in the developing placenta. In recent years, the use of transgenic 
and gene knockout approaches in mice has revealed a plethora of information that allows us 
to better understand the molecular mechanisms behind the development and function of the 
fetal-placental unit.  
 Normal placental function is critical for the uneventful fetal development and mainly 
depends upon the establishment of two major processes: a) implantation, and b) placental 
development, which includes mainly trophoblast and allantoic differentiation, labyrinth 
morphogenesis, and nutrient transport across the labyrinth. Table 1.1 summarizes the genes 
that have been found to be important for placental function and development based on 
studies with mutant mice. Moreover, this table compiles the abnormal placental phenotypes 
deriving from the related deficient gene expression. 
 In brief, the implantation process involves an intricate interaction between the 
blastocyst and the uterine endometrium. Although, the exact role of leukemia inhibitory 
factor (LIF) is not clear, in Lif-mutant mice implantation fails to occur (72), Moreover, mice 
with targeted mutation of the E26 avian leukemia oncogene 2, which controls the expression 
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of the transcription factor Ets2, demonstrate defective trophoblast invasion into the uterus 
(73).  
 After implantation, placental development depends upon signals from the ICM and its 
later derivatives for its proliferation and differentiation. Some of the first factors that are 
expressed mainly during the early post-implantation period include Cdx2, Eomes, Fgf4, and 
Esrrb (E rr2). Cdx2, a member of the caudal-related gene family, Eomes, a member of the T-
box gene family, and the growth factor Fgf4 all contribute in early trophoblast-stem cell 
maintenance and differentiation. Embryos with null mutations in either genes show poor 
development of all trophoblast cell lineages and die at or peri-implantation (74-76). Esrrb 
encodes an estrogen-related receptor ErrN that is also critical for trophoblast maintenance. 
Mutation of this gene causes embryonic lethality around E9 with complete absence of any of 
the diploid trophoblast layers of the placenta (77).  
Trophoblast giant cell differentiation is mainly controlled by the expression of Hand1, 
I-mfa (Mdfi) and Mash2 (Ascl2). Hand1 is a basic helix-loop-helix (bHLH) transcription 
factor that induces trophoblast growth arrest and giant cell transformation. Hand1-deficient 
mice show a block to giant cell differentiation (78). Mash2 is also a bHLH transcription 
factor, but with the opposite effects of Hand1. It functions either to sustain 
spongiotrophoblast cell proliferation and survival, or to giant cell differentiation. Mash2-
deficient conceptuses appear to have more giant cells than normal (79). I-mfa interacts with 
Mash2 to inhibit its transcriptional activity. Targeted deletion of this gene results in reduced 
giant cell differentiation and embryonic lethality around E10.5 (80). 
Spongiotrophoblast cell maintenance and differentiation depends upon Mash2, as 
already described, and the epidermal growth factor receptor Egfr. The exact role of this 
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receptor in placental development is not known and may vary depending upon the genetic 
background of the mice. However, multiple abnormalities that mainly lead to fetal death are 
associated with Egfr deficiency and indicate that this receptor is involved in a wide range of 
cellular activities (81). 
 Besides, the differentiation of the various placental cell types, normal development 
and function of the placenta depends also upon the coincidental morphogenesis of the 
labyrinth. This can be divided mechanistically into four major events: a) chorioallantoic 
fusion, b) early morphogenesis/branching of the labyrinth, c) extension of the villous 
branching, and d) vascularization.  
 In order for the labyrinth to form, the allantois must first attach to the chorionic 
trophoblast cells. This occurs at E8.5 and the bone morphogenetic proteins Bmp5/7, the DNA 
methyltransferase Dnmt1, the transcription factors Lhx1 (Lim1), T (brachyury), and 
Tcf/Lef1, the co-chaperon Mrj, the Fgf receptor Fgfr2, the secreted protein Wnt7b, and the 
adhesion molecules Itga4 (integrin4) and Vcam1 are thought to be involved. Some of these 
factors such as Bmp5/7, T, Lim1, and Vcam1 are known to act on the allantois, whereas 
Itga4, Mrj, Wnt7b, and Fgfr2 act on the chorion. While the exact role for each of these 
molecules is yet to be discovered mutations in most of these genes leads to failure of the 
chorioallantoic attachment and subsequent embryonic death during mid-gestation (82-91).  
 Although, the transcription factor Gmc1 does not contribute to the chorioallantoic 
fusion, it plays a critical role in the morphogenesis and initial branching of the labyrinth. In 
Gmc1 knockout mice the chorionic plate does not make folds and hence does not allow for 
labyrinth trophoblast branching. As a result there is no labyrinth formation and the embryos 
die at around E10 (92,93). 
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 Once the chorioallantoic fusion and the initial branching have occurred uneventfully, 
the labyrinth expands in size by increasing its villous branching. Several factors such as the 
transcription factors Dlx3, Fra1, Junb, Tcfeb, the Fgf receptor Fgfr, the Wnt receptor Fzd5, 
the Lif receptor Lifr, the hepatocyte growth factor receptor c-Met, the platelet-derived growth 
factor receptor L Pdgfra, the nuclear hormone receptor Pparg and Rxra, the signaling adaptor 
molecule Gab1 and Grb2 hypomorph, the hepatocyte growth factor Hgf, the platelet-derived 
growth factor chain N Pdgfb, the insulin-like growth factor Igf2, the GDP/GTP exchange 
factor SOS1, the gap junction protein Gja7 (Cx45), the heat-shock protein  Hsp84-1 
(Hsp90b), the adhesion molecules Vcam1 and Itgav (integrin LV), and the MAP kinase 
cascade molecules Mek1, p38alpha, and Kekk3 are known to be involved in labyrinth 
branching. Knockout mice that do not express one these factors appear to have smaller in size 
labyrinth, albeit to different degrees, and other abnormal histological findings (88,94-115). 
Although, the placental phenotype in these mice is well defined, the molecular basis for most 
of these defects still awaits to be elucidated. 
 In general, it is thought that the various receptors, such as c-Met, Egfr, Fgfr2, Lirf  
that have intrinsic or receptor-associated tyrosine kinase activities are stimulated upon ligand 
binding, such as binding with growth factors and other molecules (i.e Hsp84-1). Activation 
of most of these receptors may lead to activation of the adaptor protein Gab1 which in turn 
associates with SOS1 and activates Ras. Activation of Ras further activates a Ser/Thr kinase 
cascade that ultimately will activate the MAP kinases. This possible signaling pathway has 
been proposed by Hemberger and Cross using data from a combination of in vivo and in vitro 
experiments (68). 
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 While the branching of the trophoblast cells takes place, the placental blood vessels 
start to appear from the allantois. The trophoblasts regulate the blood vessels growth not only 
by providing a structural framework, but also by releasing signals and growth factors. Most 
of these molecules are unknown, but include the transcription factors Esx1, JunB, Gata2 and 
3, Arnt (Hif1b), Tcfeb, the receptor Lifr, the tumor suppressor Vhlh, the angiogenic factors 
Pgf, bFgf, Vegf, Plf and angiopoietins, the secreted glycoprotein Wnt2, the endothelial NO 
synthase, and the peptide adrenomedullin. 
 The formation of placental blood vessels occurs by angiogenesis, and therefore is 
considered to involve angiogenic factors such as Pgf, bFgf, Vegf and angiopoietins (116). 
This has been shown directly, at least for Vegf, since targeted inactivation of Vegf induces 
embryonic lethality due to vessel underdevelopment (117). Indirectly their importance has 
been demonstrated by the use of mice that do not express Arnt and Vhlh. These two 
molecules are induced during hypoxia and regulate the expression of angiogenic factors. In 
their absence there is a decrease in angiogenic factor production and the labyrinth is smaller 
in size and exhibits vascular defects (118,119). Vascular defects are also present in placentas 
that do not express Esx1 or JunB (96,120). In Esx-mutants though the labyrinth is larger in 
size, but proportionally under-vascularized (120). Moreover, Gata2 and 3, that are 
specifically expressed by trophoblast giant cells have been shown to directly regulate the 
transcription of mouse placental lactogen 1 (Pl1) and proliferin (Plf) (121). Plf encodes a 
placental-specific angiogenic factor with binding sites mainly in the uterus (122). Down-
regulation of this gene in Gata2-deficient mice leads to reduced neo-vascularization of the 
decidua, impairing the maternal vascular development in the uterus (123). 
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 Along with the growth of the placental blood vessels some of these angiogenic factors 
such as Vegf and bFgf have been implicated also in stimulating the production of 
vasodilators such as NO (124). The importance of the regulation of the vascular tone in 
normal placental function has been demonstrated in rats where the function of the vasodilator 
adrenomedullin has been inhibited. These animals present with IUGR, decreased in placental 
size, necrosis and deficient fetal placental vessel development in the labyrinth (125). The 
decreased blood flow in the fetal-placental unit may also contribute to the development of 
preeclampsia. Preeclampsia is a severe form of hypertension induced by pregnancy and is a 
common pregnancy complication in humans. 
 Finally, in addition to the normal morphogenesis of the placenta several genes have 
been found to regulate some of its critical functions, such as the nutrient transport across the 
labyrinth. Although, the mechanisms involved in this process are poorly understood, it 
appears that amino acids and glucose transfer are essential for fetal and placental growth. The 
System A amino acid transporter genes Slc38a1/SNAT1, Slc38a2/SNAT2, and 
Slc38a4/SNAT4 and the glucose transporter genes Slc2a1/GLUT1 and Slc2a3/GLUT3 seem 
to play an important role. Interestingly, both these systems seem be regulated by the growth 
factor Igf2. By abolishing fetal Igf2 as a growth demand signal, the up-regulation of both 
transporter systems is also abolished, leading to IUGR (126). Moreover, other factors such as 
the connexin gap junction protein Gjp2 (Cx26), and the hormone placental lactogen 1 are 
also involved in nutrient transport. Cx26 is expressed in the labyrinth and Cx26-deficient 
fetuses show severe IUGR and die due to impaired transplacental transport of glucose (127). 
The exact role of placental lactogen in nutrient transport remains controversial, but it is 
thought to modulate fetal Igf production and therefore control the demand for nutrients 
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(128,129). In general, the placenta functions as a nutrient sensor and may alter placental 
transport functions according to the ability of the maternal supply line to provide nutrients.    
 From all of the above, it is clear that placental growth, development and function is 
regulated by a broad range of genes. These genes can be expressed by specific cell types at 
different stages of development and sometimes appear to have overlapping activities. 
Placental regulation becomes even more complex considering the dense network that these 
gene products establish and the extensive crosstalk among the various pathways. The gene 
knockout mice have provided us with a vast understanding of the placental biology, but still 
limit our knowledge to the studied available mouse models. It is very likely that genes other 
than those described are also critical for the generation of a normal placenta. Finally, it is 
reasonable to assume that any exposure to a challenge that could create a permanent genetic 
(i.e mutation) or epigenetic (i.e promoter hypermethylation) modification, or a temporary 
alteration in the expression of these genes in utero may affect normal placental development 
and function and consequently fetal growth and development.       
DNA Methylation  
 In addition to the four standard nucleobases [adenine (A), thymine (T), guanine (G), 
cytosine (C)], DNA consists also of methylated bases such as N6-methyladenine, 5-
methylcytosine and N4-methylcytosine (Fig.1.3). These bases are natural components of the 
DNA and occur enzymatically after replication. Hence, they differ from other chemically 
modified bases formed by alkylation or oxidative damage of the DNA. In higher eukaryotes 
DNA methylation is the only covalent modification of the DNA and is introduced in a 
sequence-specific manner, usually at palindromic sites. The methylation does not interfere 
with the Watson-Crick pairing properties, but the methylation group is introduced in the 
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major groove of the DNA, where it can be easily detected by proteins interacting with the 
DNA.  Depending on the species, 2-8% of all cytosines found in the DNA are methylated. 
Most of these cytosines are found in CG sequences, and in fact, the majority of the CG 
sequences are methylated (60-90%). Thereby, a pattern of modified and unmodified CG sites 
is created. Usually the cytosine residues on both strands of this palindromic sequence are 
methylated providing a “fully methylated” site. Since, after replication, the newly 
synthesized DNA strand does not carry any methylation, each daughter duplex has one 
methylated and one unmethylated strand. Such a site is called “hemimethylated”. The 
perpetuation of the methylated site now depends on what happens to the hemimethylated 
DNA. If no modification occurs and replication takes place, the hemimethylated condition 
will be perpetuated on one daughter duplex, but the site will become unmethylated on the 
other daughter duplex. However, after the initial replication, the original pattern of 
methylation can be reestablished by a maintenance methyltransferase (MTase) that 
specifically modifies hemimethylated but not unmethylated target sites. Therefore, the 
pattern of DNA methylation can be stable over cell divisions and hence somatically inherited. 
Nevertheless, methylation patterns can also be edited either by adding methyl groups at new 
positions via the function of de novo methylases or by the removal of methyl groups by 
demethylases. This makes DNA methylation a unique way to encode information in a stable 
but reversible manner (130,131).  
 The presence of CG dinucleotides in the DNA is not random. Usually they are found 
in CpG islands, that are genomic regions of approximately 1 Kb that have a high G, C 
content, are rich in CG dinucleotides, and are commonly associated with promoter regions of 
genes (132). Although the exact mechanism that selects which specific CG site will be 
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methylated in a CpG island has not been elucidated, the presence of these islands in the 
promoter renders DNA methylation a critical player in the control of gene expression.  
Methylation of CG sequences in the promoter region of genes usually leads to 
silencing of the particular gene (133,134,-135). Repression of gene expression is thought to 
occur through the following mechanisms: a) Directly, by inhibiting the binding of 
transcription factors, such as AP-2, c-Myc/Myn, E2F, and NFB with their binding elements. 
b) Indirectly, by recruiting 5-methylcytosine binding proteins which act as repressors of gene 
transcription. c) By triggering histone deacetylation which induces chromatin condensation 
and thereby strong and stable repression of gene expression (131). 
 It is evident, that gene silencing induced by DNA methylation can have detrimental 
effects for the individual if “helpful” genes are affected. One such well studied example is 
tumor development. In many of these cases, epigenetic modification of the methylation 
patterns of tumor suppressive genes results in the down-regulation of the expression of these 
genes, which leads to uncontrolled tumor growth (135,136). However, for the most part, 
DNA methylation is considered to have beneficial effects.  Given its properties to encode 
information in a stable but reversible manner, DNA methylation is ideally suited to control 
processes like cellular differentiation or development. Hence in mammals, X-chromosome 
inactivation and genomic imprinting are both mediated by DNA methylation.  
Genomic Imprinting and its Role in Placental Development 
 Although experimental evidence suggests that genomic imprinting evolved 
approximately 180 million years ago, it was only discovered in 1984 (137-139). Genomic 
imprinting is defined as an epigenetic modification of a specific parental chromosome in the 
gamete or zygote that leads to differential expression of the two alleles of a gene in the 
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somatic cells of the offspring (140). In fact, in the majority of cases, one parental allele is 
completely silenced resulting in monoallelic gene expression. It is important to note, 
however, that imprinted (i.e. monoallelic) expression of a given gene can show both spatial 
and/or temporal specificity (141). 
 The basic principle that governs this phenomenon lies in DNA methylation. 
Specifically, the imprint is transmitted as a certain pattern of methylation of imprinted genes 
which is set in the gonads during spermatogenesis and oogenesis. After fertilization the 
imprint persists in the somatic cells for the rest of the life of the individual. In contrast, in the 
germ cells the imprint must be erased and reset, because the new imprint depends on the sex 
of the individual. Hence, the paternal and maternal copies of imprinted genes will obtain a 
female imprint in oocytes and a male imprint in sperms. Therefore, this process depends on 
both characteristic features of DNA methylation: stable and inheritable silencing of genes 
and the possibility to alter the encoded information if required (131).   
Imprinted genes represent only a small subset of mammalian genes that, although 
dispersed throughout the entire genome, are often found in clusters that may extend over 1-2 
Mb. The reason for this clustering is not fully understood, but it seems that the 
interaction/control between imprinting genes is facilitated by the physical linkage of the 
genes and the shared regulatory elements (142). Such elements include enhancers, silencers, 
insulators, and activators, all of which have the potential to be epigenetically regulated. Of 
particular interest are the so called “imprinting control regions” (ICRs), which regulate 
epigenetic modifications and imprinted expression of several genes throughout clusters 
(143). Deletions and inappropriate methylation of these regions are often associated with loss 
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of imprinting and human diseases (i.e. Prader-Willi syndrome, Angelman syndrome, 
Beckwith-Wiedemann syndrome, etc).  
Another characteristic of imprinted genes is that they are unusually rich in CpG 
islands. In the mouse 88% of imprinted genes are associated with CpG islands versus 47% in 
the whole genome. These CpG islands are frequently surrounded by direct repeats and both 
are involved in conferring or maintaining differential methylation of the imprinted allele 
(144). Finally, differential allele-specific DNA methylation is usually localized to regions 
termed differentially methylated regions (DMRs). These have different properties and 
methylation patterns during development in germ and somatic cells. DMRs are generally 
CpG rich, fulfilling most of the times the criteria of a CpG island, and often contain repeat 
elements and ICRs. Deletion of a DMR also results in loss of gene imprinting (142).  
A comprehensive and growing list of putatively imprinted mammalian genes derived 
from published literature is summarized in the Catalogue of imprinted genes and parent-of-
origin effects (www.otago.ac.nz/IGC) and the MRC Mammalian Genetics Unit mouse 
imprinting data website (http://www.mgu.har.mrc.ac.uk/research/imprinting). Based on these 
data, 53 and 96 genes are considered to be imprinted in humans and mice respectively. From 
these, only 37 have been verified to be shared in both species. The imprinted genes are 
located in 27 chromosomal regions (16 in humans and 22 in mice). Of the imprinted 
components, 63 are protein-coding genes (35 in humans and 54 in mice) with only 26 
common to both species. The remaining noncoding RNAs include antisense transcripts, small 
nucleolar RNAs, microRNAs, pseudo-genes and other RNAs of unknown function. Some of 
these imprinted noncoding genes appear though to regulate the imprinting of adjacent 
protein-coding genes (i.e. H19/IGF2) (145). Although the number of imprinted genes is 
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constantly growing, it is still very low relative to the total amount of genes in the genome. 
However, genome-wide studies, that predict murine imprinted genes based on common 
sequence features from other known imprinted genes, have estimated that the actual number 
of these genes may be much higher. Depending upon the study and the criteria used, potential 
imprinted genes could range from 100 to 2,114 (146-148). 
The evolution of imprinting in this selected group of genes has mainly been explained 
by the “genetic conflict theory”. Based on this hypothesis there are differential interests 
between maternal and paternal genomes with regard to resource allocation. Paternally 
expressed genes have been selected to maximize resources from the mother, whereas 
maternally expressed genes have evolved to balance resource allocation to the offspring. 
Consequently, imprinted genes are expected to play a significant role in the growth and 
development of the placenta and the fetus.  
 To date, many imprinted genes have been shown to be expressed in utero and are 
considered to be involved in the control of fetal and placental growth and development. As 
expected, in fetal tissues paternally expressed genes enhance fetal growth whereas maternally 
expressed genes suppress it. Such directional effects on fetal growth based on the parent-of-
origin expression of imprinted genes have been reported in mouse knockout and transgenic 
experiments. For example, fetuses from knockouts of paternally expressed genes, such as 
Igf2, Ins2, Peg1, Peg3 and Mest, demonstrate IUGR. On the other hand, fetuses from 
knockouts of maternally expressed genes H19, and Igf2r, which interact with the IGF and 
insulin systems of growth factors,   show overgrowth (144,149). 
Imprinted genes are also expressed in placental tissues, and mouse knockout 
experiments have demonstrated that these genes can also affect fetal growth.  Two 
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mechanisms by which this may occur have been proposed: a) Imprinted genes regulate the 
growth and development of the placenta which is critical for the establishment of an adequate 
and functional surface for nutrient and waste exchange between the fetus and the mother. b) 
Imprinted genes may affect the supply of resources to the fetus via effects on specific 
transporters and channels involved in transplacental solute exchange (150). 
Specifically, in mice, placental growth is controlled by these genes in a similar 
fashion as in the fetus. Lack of expression of Igf2 and Peg3 from trophoblasts, or of Peg1 
from labyrinth blood vessels, or of Mest from the chorionic plate  results in a smaller size of 
placenta (65-85%, at late gestation). Contrarily, deletion of maternally expressed H19, Igf2r,
p57Kip2, Ipl, Phlda2, and Meg1/Grb10 leads to placental hyperplasia (around 140%). These 
alterations in the size of the placenta are often accompanied by disanalogous changes in the 
proportions of the three placental layers (giant cell, spongiotrophoblast, and labyrinth). This 
usually depends upon the placental layer or layers that express the imprinted genes and which 
are usually more affected. Besides the structural changes within the placenta that may render 
this organ less efficient, other epigenetic genes, such as Mash2 seem to play a more 
detrimental role in placental development. Mash2 is a paternally expressed gene imprinted 
only in placental tissues. Mice lacking the expression of this gene die in utero due to 
placental failure (79). Many other imprinted genes such as Gatm, Sgce, Peg10, Necdin,
Magel2, Tssc4, Dcn, Impt1, Dpk1, Rtl1, Dio3, and Gtl2 are also considered to be important 
for placental growth and development, but experiments with knockout mice of these genes 
are not available to establish a specific role in the placenta and phenotype (164). Finally, 
imprinted genes on the X chromosome like Esx1, Cited 1, Gpc3, and Chm also contribute to 
placental growth, and deficient mice demonstrate placentas with abnormal structure (164).  
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Regarding the transplacental exchange of nutrients several mechanisms are involved 
in this process and briefly include i) transport by selective transporter proteins, such as ion 
channels, exchangers, co-transporters (e.g. system A amino acid transporter) and pumps and 
ii) passive diffusion. Studies have demonstrated that imprinted genes regulate the function of 
selective transporter proteins. Maternally expressed Slc222, Slc223 and paternally 
expressed Impt1/Sclc221l are imprinted exclusively or predominately in the placenta. The 
first two are linked to Igf2r and the third to Igf2. They all encode organic cation transporter 
proteins and knockouts of these genes reveal effects on placental transfer functions. 
Moreover, the paternally expressed Scl384 (Ata3) encodes a system A amino acid 
transporter. However, loss of imprinting for this gene does not affect the phenotype of the 
mice suggesting that Ata3 can be compensated for by other system A amino acid 
transporters, such as Slc38a1 or Slc38a2. Finally, Igf2 has recently been shown to regulate 
the diffusional exchange characteristics of the mouse placenta and in fact, in Igf2 mutant 
mice the diffusing capacity was reduced to 40% (151).  
It is important at this point to note, that similar experiments cannot be employed in 
humans and thus the role of these genes in the development of the human placenta is for the 
most part speculative. However, array experiments using placental tissues from IUGR fetuses 
revealed a down-regulation of a number of imprinted genes that are thought to play a role in 
placental/fetal growth (152). Additionally, environmental factors such as nutrition that are 
able to induce loss of imprinting have also been associated with IUGR (--).  
All the above provide the basis to assume that any epigenetic factor that can affect 
methylation patterns during pregnancy, may confer risk for normal imprinting and affect 
placental and fetal growth and development.         
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Insulin-like growth factor 2 (Igf2) and its Role in Placental Development 
Igf1 (somatomedin C), Igf2 (somatomedin A) and insulin are related polypeptides 
that have a high degree of sequence homology and exhibit a similar spectrum of biological 
activities. The Igfs play a key role in regulating fetal and placental growth. They are not only 
mitogenic, but also promote differentiation, migration and aggregation, and inhibit apoptosis, 
all of which are involved in the development of the placenta (153). In general, placental 
growth is decreased in mice lacking the Igf2 gene, although this does not occur in mice 
lacking Igf1, suggesting that Igf2 has a relatively greater role in placenta development (154). 
Igfs interact with 3 distinct cell receptors (Igf1r, Igf2r and an unknown receptor). They bind 
with equal affinity to Igf1r, but Igf2 has a 100-fold higher affinity for Igf2r. A null mutation 
of Igf1r gene results in slowing of prenatal growth, whereas similar mutation of Igf2r, which 
clears Igf2 from plasma and tissue fluids, results in large birth weights with lethality to nearly 
all mutant fetuses (154,155).  The functions of Igfs is also modulated by 6 binding proteins 
(Igfbp1-6) which control their availability for their receptors.  
In the mouse placenta, Igf2 is expressed during vascularization in the mesoderm and 
its constituent blood vessels. Later it is expressed in the labyrinth trophoblasts.  Around E9.5-
E12.5 Igf2 is expressed by the spongiotrophoblasts, but after E12.5, when glycogen cells 
appear, Igf2 becomes more abundant in these cells relative to the spongiotrophoblasts. 
Finally, some of the giant cells also express Igf2 (153). However, although Igf2 is expressed 
shortly after implantation its action on growth is only seen from E13 onward (156). 
Igf2 is an imprinted gene. In mice it is located at the distal aspect of chromosome 7 
and is part of a gene cluster of imprinted genes lying between Obph1 and Impt. It is flanked 
5’ by Ins2 and 3’ by H19, a linkage group that is also conserved in humans too. As depicted 
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in Figure 1.4 this approximately 28 kb gene consists of 4 promoters (P0, P1, P2 and P3). 
These promoters are active in different tissues or in the same tissues but at different periods 
of development. For example, in general, P0 is functional in placental tissues whereas P3 and 
P4 are active in fetal liver. In the adult liver however, P1 is driving Igf2 expression. The Igf2 
gene contains also 6 exons and 2 pseudo-exons. Based on their location the different 
promoters create 4 partially overlapping transcription units. However, exons 1-3 are spliced 
out and only exons 4-6 encode the 180 amino acid Igf2 precursor protein. Since exons 4-6 
are common in all transcribed products all promoters end up encoding the same final product. 
In addition, 2 CpG islands are present, one in the P2 region and the other upstream of P1. 
These CpG islands are always unmethylated irrespective of the parental origin. Moreover, an 
interspersed repetitive sequence family, the B2 family, is located upstream of P0, while a 35-
times repetition of a GC-rich consensus sequence, AGGCCTGAGCC, is present in the 
pseudo-exon 2 region (157). Finally, the Igf2 gene consists of 3 differentially methylated 
regions (DMRs) rich in CG dinucleotides. Specifically, DMR1, situated 3 Kb upstream of P1 
exhibits a mosaic pattern of methylation, with an excess of methylated sites in paternal 
derived DNA. However, it is unclear whether these quantitative differences in allelic 
methylation contribute to differential parental allelic activity. Therefore, the function of 
DMR1 remains elusive. The second DMR (DMR2) is located between P0 and P1, but is not 
considered to be implicated to the actual primary imprinting mechanism. Rather, DMR2 is 
believed to act as a tissue-specific silencer since it is consistently methylated on the active 
(paternal) allele in tissues where Igf2 is expressed (158). In contrast to the DMR1 and 2 
regions, which are paternally hypermethylated in the fetus, in the placenta a recently 
discovered DMR0 exhibits maternal hypermethylation. The 1 Kb DMR0 includes the 
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placenta-specific promoter region P0 and extends downstream close to the pseudo-exon 2. 
Interestingly, in the fetus, where P0 is not active, both alleles are heavily methylated 
suggesting that the methylation status of DMR0 may, in part, control the expression of this 
imprinted gene in the placenta (159).    
Imprinting of Igf2 is also considered to be controlled, in part, by an imprinting control 
region (ICR) located between the Igf2 and H19 genes. This ICR is differentially methylated 
in the two parental alleles and contains four conserved CTCF binding sites. CTCF is a zinc-
finger protein that acts as an insulator. The insulating effects of CTCF depend upon the status 
of DNA methylation of these binding sites. In general, ICR is unmethylated in the maternal 
allele which allows the binding of CTCF in this region. Once bound, it insulates the maternal 
promoters of Igf2 from 2 enhancers, found downstream of H19, and hence silences the 
maternal expression of Igf2. At the same time the enhancers become accessible to the H19 
maternal promoter, which therefore becomes active. On the other hand, on the paternal allele 
ICR is methylated and inhibits CTCF binding, thus failing to insulate the paternal Igf2 
promoters from accessing the enhancers. As a result, Igf2 is monoallelically expressed from 
the paternal allele and H19 is expressed from the maternal allele (160-162). However, 
although this is true in peripheral tissues examined, in the CNS there is biallelic expression of 
Igf2. In these tissues allelic methylation pattern of the ICR are similar with those of the 
peripheral tissues. However, histone methylation correlated well with Igf2 allelic expression 
(163).  
These results clearly demonstrate that Igf2 imprinting is complex and not fully 
understood. The Igf2/H19 gene regulation by CTCF seems to be a major player, but other 
factors such as histone methylation, promoter methylation and other yet undiscovered 
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mechanisms may also be involved. Imprinting control becomes even more complicated 
considering tissue specificity. In the placenta although Igf2 is known to be paternally 
expressed the exact mechanism of imprinting has not been elucidated yet. The fact that the 
placenta uses a specific and unique promoter that contains a CTCF binding site and 
differentially methylated regions certainly adds more to the already exciting complexity of 
Igf2 imprinting.         
The role of Igf2 in the developing fetus and placenta has been well established. The 
fetal promoters P3 and P4 control the expression of Igf2 in fetal tissues, spongiotrophoblast 
and glycogen cells of the placenta as well as endothelial cells in the capillaries of the 
labyrinth. On the other hand, the placenta-specific P0 promoter directs the expression of Igf2 
in the labyrinth trophoblasts (164). As described previously, in Igf2 null mice the fetuses 
appear with IUGR (60% of wild-type) and the placenta are restricted in size. Interestingly, in 
mice where the Igf2 transcripts derived from P0 were disrupted the deficiency in growth of 
the placenta was as great as with that observed in the Igf2 null mice, suggesting that the P0 
promoter plays the principle role in placental growth. Moreover, deletion of the P0 
transcripts results in late gestation fetal IUGR. At birth, P0 mutant pups are 69% of normal 
birth weight. This is followed by post-natal catch-up growth, which is completed three 
months after birth (165). Finally, as in the Igf2 null mice, the P0 mutant placentas 
demonstrate a decrease in their diffusing capacity (40% of wild-type) and altered transporter 
expression. Both of these are related to the observed fetal IUGR since impairment of these 
mechanisms leads to a deficient supply of nutrients from the mother to the fetus (151). 
Hypothetical Model 
32
 Based on all the above information, we hypothesize that maternal infection of 
pregnant mice with C. rectus 314 will lead to dissemination of the bacteria to the placentas 
and fetuses. This bacterial challenge will induce IUGR accompanied by impairment of the 
growth and function of the placenta. Specifically, we are expecting to find structural 
alterations in the placenta of IUGR fetuses, such as a decrease in the labyrinth that would 
justify this pathologic fetal phenotype. Since normal placental development is controlled by 
growth-related genes we predict that the expression of a large number of genes known to be 
involved in placental development will be down-regulated by the placental 
infection/inflammation. Among the affected genes important for placental growth we expect 
to find imprinted genes. Knowing that the expression of imprinted genes is regulated by the 
methylation patterns of these genes, we hypothesize that placental infection/inflammation 
will induce changes in these methylation patterns (i.e. promoter hypermethylation) leading to 
loss of imprinting of these genes.  
 To investigate our hypothesis we have divided our experiments in four specific aims: 
1) Evaluate whether C. rectus 314 infection induces IUGR in mice and whether the 
bacteria disseminate to the placenta. 
-To assess for  IUGR we will measure the fetal weight and the fetal crown-rump length 
-To assess for bacterial dissemination we will evaluate: a) the presence of bacteria in the 
placenta and fatal brains with PCR, ii) whether the bacteria are alive in these tissues using 
culturing techniques, and iii) if bacteria can invade non-phagocytic cells applying 
immunohistochemistry.  
2) Evaluate whether C. rectus 314 infection mediates structural alterations in murine 
placentas which could contribute to IUGR.  
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-We will weigh the placenta and use morphometry to assess structural changes within this 
organ. 
3) Evaluate whether C. rectus 314 infection mediates changes in the expression of genes 
associated with the development and growth of the placenta and the fetus. 
- We will use the microarray technology to assess the differential expression of genes related 
to placental and fetal growth and development, as well as the expression of imprinted genes. 
-We will verify the expression of genes of interest with Quantitative PCR. 
4) Evaluate whether C. rectus 314 infection mediates hypermethylation of the Igf2 
promoter which could lead to the reduction of gene expression of Igf2.
-We will assess whether the downregulation of imprinted genes is associated with promoter 
hypermethylation using the bisulfite treatment and sequencing technique. We will use Igf2 as 
the imprinted gene of interest.  
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Figure 1.1. Potential sites of bacterial infection within the uterus. Picture adapted from 
reference 18. 
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Figure 1.2. Early development of the mouse placenta, from implantation (E3.5) to 
placental layer formation (E12.5). ICM, inner cell mass. Picture adapted from reference 67. 
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Figure 1.3. Structures of methylated bases occurring in DNA. Figure adapted from 
reference 131.  
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Figure 1.4. Genomic map of mouse Igf2. P, promoter; E, exons; U, pseudo-exons; DMR, 
differentially methylated region. The graph is based on the sequence provided by GenBank 
accession # U71085. 
P0 P1 P2 P3 1 Kb 
DMR0 DMR1 DMR2 CpG islandCpG island GC rich 
E6E3E1 E2 E4 E5U1 U2
B2 
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Table 1.1. Genes important for placental function and development based on studies on 
mutant mice. Main functions and abnormal placental phenotypes derived from deficient 
expression of these genes are also presented.  
 
Gene Main Function   Phenotype 
Lif Implantation No implantation 
Ets2 
Trophoblast invasion in 
uterus 
Defective trophoblast invasion into the 
uterus 
Cdx2 
Eomes 
Fgf4r 
Poor development of all trophoblast cell 
lineages  Die at periimplantation 
Esrrb 
Early tropholast-stem cell 
maintenance and 
differentiation Absence of all diploid trophoblast layers                 
Death at E9 
Hand-1 No giant cells 
I-mfa (Mdf1) Less giant cells and death at E10.5 
Ascl2 
(Mash2) 
Trophoblast giant cell 
differentiation 
More giant cells 
Egfr 
Multiple cellular 
activities Mainly fetal death 
Bmp5/7 
Dnmt1 
Lhx1 (Lim1) 
T (brachyury)
Tcf/Lef1 
Mrj 
Fgfr2 
Wnt75 
Itga4 
Vcam1 
Chorioallantoic fusion 
Failure of chorioallantoic attachment                        
subsequent embryonic death at mid-
gestation 
Gcm1 Morphogenesis and initial branching of the labyrinth 
No labyrinth              
Death at E10 
Dlx3 
Fra1 
Junb 
Tcfeb 
Fgfr2 
Fzd5 
Lifr 
c-Met 
Pdgfra 
Pparg 
Rxra 
Gab1 
Grb2 
Labyrinth branching Smaller labyrinth                                                        
Abnormal histological findings 
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Hgf 
dgfb 
Igf2 
Sos1 
Gja7 (Cx45) 
Hsp84-1 
(Hsp90b) 
Vcam1 
Itga4 
Mek1 
p38alpha 
Kekk3 
 
Esx1 Large labyrinth with vascular defects 
Gata2/3 Reduced neovascularization of the decidua 
Arnt (Hif-b) 
Vhlh 
Junb 
Tcfeb  
Lifr 
Smaller labyrinth with vascular defects 
Vegf 
Angiogenesis                    
Blood vessel underdevelopment                               
Embryonic lethality 
Am Angiogenesis                     Vascular tone control 
IUGR                                                                                  
Smaller placenta                                                         
Necrosis and deficient fetal placental vessel 
development in labyrinth 
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Abstract 
Background: Maternal periodontal infection has been associated with increased risk 
of prematurity and low birth weight.  Infection and inflammatory pathways that mediate 
prematurity have also been implicated in neonatal developmental impairments. The objective 
of this study was to determine whether maternal C. rectus infection that induces fetal growth 
restriction in a mouse model also compromises neonatal pup survival, growth and 
neurodevelopment.  
Methods: Timed pregnant mice were challenged with C. rectus on gestation day-7.5. 
One group of animals was sacrificed on E16.5 for placental histology and measurement of 
fetal brain mRNA expression of TNF-L and IFN-Y. Another group of animals was allowed to 
deliver to follow pup survival, growth and brain structure at day-9.  
Results: C. rectus challenge resulted in abnormal placental architecture with 
inflammation and a 2.8-fold increase in fetal brain expression of IFN-Y, Z[p=0.04). Pup birth-
weight was unaffected by C. rectus exposure, but lethality was 4.1-fold higher after one-
week. Ultrastructurally, the 9-day neonatal brain tissue displayed cellular and myelin 
alterations consistent with white matter damage. 
 Conclusions: Maternal C. rectus infection induces placental inflammation and 
decidual hyperplasia as well as concomitant increase in fetal brain IFN- Y. Maternal infection 
increased pup mortality and preliminary findings demonstrate ultrastructural changes in the 
hippocampal region of the neonatal brain, in a manner analogous to the effects of maternal 
infection on white matter damage seen in humans. Thus, the threat of maternal oral infectious 
exposure during pregnancy may not be limited to the duration of gestation, but may also 
potentially affect perinatal neurological growth and development. 
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Introduction 
Prematurity (birth that occurs at less than 37 weeks of gestation) and/or low birth-
weight (LBW), defined as <2,500 g, and very low birth weight (VLBW), defined as <1,500 g 
are the second largest cause of neonatal mortality (1). From 1980 to 2000, the percentage of 
LBW infants increased by 11.8% and that of VLBW infants increased by 24.3% in the 
United States (1) and, among survivors, LBW is a major contributor to long-term disability. 
(2) The quality of the intrauterine environment, as well as the duration of the gestation in 
utero have been suggested (3,4) to be critical determinants of long-term well being of the 
individual, ranging from cognitive and learning skills to susceptibility to heart disease. 
Infectious exposure of the mother during pregnancy is believed to be one factor that can 
trigger in utero fetal stress, and, thus, may ultimately contribute to long-term growth and 
developmental problems that may extend throughout the lifetime of the neonate. 
Periodontal disease has been reported as a potential maternal concomitant infection 
that may increase the risk of prematurity, low birth weight and a birth weight below the 10th 
percentile (small for gestational age) (5,6) However, there are no data regarding the role of 
maternal periodontal disease on neonatal morbidity following delivery. It has been 
demonstrated through animal models that the potential for infections with oral organisms or 
challenges with lipopolysaccharide (LPS) isolated from oral organisms can stimulate 
intrauterine fetal stress and impair fetal growth. This effect has been demonstrated with 
Porphyromonas gingivalis (P. gingivalis) using a chronic subcutaneous infection model and 
also in a model of experimental periodontitis (7,8). In both studies the infection was 
associated with an inflammatory challenge to the fetus, as measured by increases in amniotic 
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fluid prostaglandin E2 (PGE2) and TNF- and attendant growth restriction.  These animal 
infection models of growth restriction provide important proof-of-concept experiments that 
raise the possibility that distant, low grade oral infections might trigger inflammation of the 
intrauterine fetal unit. 
Subsequent experiments using either P. gingivalis or Campylobacter rectus (C. 
rectus) challenge in pregnant mice (7-9) have provided further evidence for: 1) an increase in 
maternal inflammatory serum markers of stress; 2) dissemination of organism from the site 
of infection first to the maternal liver and subsequently spreading to the uterus and the 
placenta(s); and 3) an increase in biochemical markers of placental inflammation and stress. 
These studies have shown the ability of oral organisms to translocate hematogenously to the 
placental tissues and cause growth restriction of the fetus. Interestingly, following a 
challenge of P. gingivalis to a pregnant mouse, those littermates that have placentas 
containing PCR-detectible P. gingivalis are growth restricted, whereas those with placentas 
without detectible P. gingivalis are normal sized. This suggests that direct placental tropism 
is associated with growth restriction; however, placental translocation of the organism is 
apparently not an absolute requisite for fetal damage. A 1994 study by Collins and colleagues 
(10) examined the effects of P. gingivalis LPS challenge and demonstrated that LPS can 
mediate abnormalities in fetal growth and development.  Thus, the effects of maternal 
infection with oral organisms on fetal development may be mediated, in part, by both 
maternal inflammatory responses and direct placental impairment following translocation of 
bacteria or LPS.  
Although periodontal infections are mixed infections caused by a complex of Gram-
negative anaerobes, findings from our human studies point to the key role of one oral 
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pathogen, Campylobacter rectus, in mediating fetal exposure and morbidity. This finding 
suggests that the oral Campylobacter species associated with periodontal disease may be as 
fetotoxic as other well-known related Campylobacter species such as C. fetus or C. jejuni and 
that the presence of maternal periodontal disease during pregnancy may serve to create the 
oral wound that permits maternal dissemination and fetal exposure to C. rectus in utero 
(11,12). 
 Recent studies (9) using C. rectus challenge on embryonic day 7.5 (E7.5) via a 
subcutaneous chamber infection model in pregnant dams has shown that this organism can 
trigger fetal growth restriction as seen on day E16.5. In the current experiments, we sought to 
determine whether C. rectus challenge was associated with histological evidence of placental 
damage or impaired growth. Furthermore, although the potential effects of infectious 
exposure on eliciting fetal growth restriction appears to be well established from these 
experiments, the effects on fetal brain development, which is often impaired in human cases 
of growth restriction, is unknown. For this reason we performed experiments to determine 
whether C. rectus exposure on day E7.5 was sufficient to initiate increases in brain mRNA 
expression of two key inflammatory mediators of neural damage,[ TNF-Z and IFN-, that 
could be assessed at E16.5. In addition, the effect of fetal exposure on pup survival, growth 
and neurodevelopment was studied. 
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Materials and Methods 
Animal Husbandry 
 
All procedures were in accordance with the animal welfare guidelines and approved 
by the University of North Carolina-Chapel Hill Institutional Animal Care and Use 
Committee. BALB/c mice were housed under controlled and standardized conditions, with 
12-hour light-dark cycles (0700-1900 light). Regular mouse diet and water were provided ad
libitum. Females were enrolled in the experiments at approximately 6 weeks of age, at which 
time a steel chamber was implanted subcutaneously.  After a period of healing, they were 
mated overnight with males of the same strain. The next morning, females were removed 
from the male cages and examined for vaginal plugs. If a plug was found, that day was 
recorded as embryonic day E0.5.   
Chamber Implantation 
 
To investigate the effects of a remote, localized infection, a mouse chamber model 
was used similar to that described by Lin et al.(7) A stainless steel, open-ended cylindrical 
coil spring (chamber) approximately 1.0 cm x 0.4 cm was implanted subcutaneously into the 
dorsolumbar region of each female mouse. The site was allowed to heal for at least 2 weeks 
before mating. In previous chamber studies we used P. gingivalis A7436 that was a relatively 
virulent strain in this model and requires pre-treatment of the mice with heat-killed 
organisms to elicit a protective antibody response to prevent the animal from sepsis or death 
following challenge with live bacteria. However, pilot ascending dosage studies with C. 
rectus 314 (data not shown) showed that the organism was well tolerated by the animals and 
pre-treatment was not needed.  
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Challenge with C. rectus  
In each experiment, one group was challenged with C. rectus 314 and the other group 
received saline (control). Bacteria were grown on enriched tryptic soy agar (ETSA) plates 
(Anaerobe Systems, Morgan Hill, CA). On day E7.5, pregnant mice in the control groups 
received an intra-chamber injection of 0.1 ml of phosphate buffered saline (PBS), while the 
pregnant mice in the test groups received an intra-chamber injection of 0.1 ml of 109 CFU/ml 
live C. rectus strain 314. 
Sample collection 
Pregnant mice were randomly divided into four groups of eight. Two groups of 
pregnant dams (experiment A, eight controls and eight challenged mice) were sacrificed on 
day E16.5 in order to collect placentas and fetuses, while the other dams (experiment B, eight 
controls and eight challenged mice) were allowed to deliver and care for their pups.  In 
experiment A, fetuses were collected and weighed on day E16.5.  Fetal growth restriction 
(FGR) was defined as fetal weight <0.37g, which was 2 SD below the pooled average weight 
of fetuses from unchallenged animals. 
Placental Histology 
In order to determine the effects of C. rectus infection on placental structure, pregnant 
females were sacrificed on day E16.5. Placental tissues were collected and processed at 
E16.5 to examine for changes in the dimensions of the labyrinth zone, expressed as a ratio of 
the total labyrinth to the junctional (trophoblasts plus decidua) zone. Placentas were fixed in 
4% paraformaldehyde, bisected sagittally, processed, and embedded in paraffin. Sections (7 
µm) were stained using standard hematoxylin and eosin (H&E) protocol. Systematic random 
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sampling was used to select, without bias, sections for analysis. Morphometry was performed 
on five placentas from control dams and five from FGR fetuses from C. rectus challenged 
mice, measuring three sections in each sample. The areas (in mm2) of junctional zone and 
placental labyrinth were calculated using the “Image J” software (http://rsb.info.nih.gov/ij/), 
the mean values were computed for each placenta and pooled for each treatment group. 
Significant differences in percentage of labyrinth were determined by t-test. Placentas were 
also examined for histological evidence of inflammatory cell infiltrate.  
Fetal Brain Measurements of IFN- and TNF-
Fetal brain samples from experiment A were microdissected on day E16.5 and brain 
mRNA was extracted and analyzed for TNF- and IFN- expression by RT-PCR relative to 
glyceraldehyde 3-phosphate-dehydrogenase (GAPDH), a housekeeping gene. This was used 
as a semi-quantitative approach to evaluate the level of mRNA expression of these two 
inflammatory mediators in the brain. Firstly, total RNA from each brain was extracted using 
Tri Reagent (Sigma, St. Louis, MO).  Samples were homogenized and digested in 500 µl Tri 
Reagent for 5 minutes at room temperature.  After adding 100 µl chloroform with vigorous 
shaking, samples were centrifuged at 12,000xg for 15 minutes at 4°C. The aqueous phase 
containing RNA was collected and mixed with 250 µl of isopropanol. After centrifugation, 
the RNA pellet was washed with 75% ethanol. After air drying, 10 µl DNAse/RNAse-free 
water was added to dissolve the RNA pellet. The concentration of each RNA sample was 
adjusted to 1µg/µl. cDNA was synthesized using a first-strand cDNA synthesis kit 
(Amersham Pharmacia Biotech, UK). Briefly, 1 µg total RNA was reverse-transcribed in a 
total volume of 15 µl using Cloned FPL CpureMurine Reverse Transcriptase, and first-
strand cDNA was synthesized using Not I-d (T)18 Bifunctional Primer according to standard 
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procedures. Then, specific primers were used for PCR to obtain double-stranded DNA 
(amplicon) of IFN- (13), TNF- (14) and GAPDH for each sample. Following PCR 
amplification, amplicons (10 µl) were separated by 2% TAE agarose gel electrophoresis and 
stained with 0.5 µg/mL SYBR Gold (Eugene, OR). We used LumiAnalyst combined with 
Image Analysis Software Version 3.1 (Boehringer Mannheim GmbH, Germany) to measure 
the relative intensity of bands corresponding to specific amplicons. Relative levels of mRNA 
were expressed by calculating the ratio of each band’s intensity (i.e., specific DNA of each 
sample) normalized to the intensity of the GAPDH signal. Significant differences in relative 
intensity were determined by t-test. 
The primer sequences used for semi-quantitative RT-PCR and conditions applied for 
PCR reaction are shown in Table 2.1. 
Neonatal Monitoring  
Pregnant mice from experiment B (eight C. rectus challenged and eight saline 
controls) were allowed to deliver and care for their pups. Pup weight, viability and overall 
appearance were examined daily until weaning age. Mean pup weight was determined for 
each litter in each of the two groups. Statistical differences in weight gain between groups of 
pups were evaluated by t-test and using pooled estimate of mean litter weight for each group 
and pooled variance estimates. Hazard ratios of pup demise between challenged and control 
animals were determined using a Cox regression model. 
Brain Histological analysis 
To determine the area to be studied through electron microscopy, four samples from 
experiment B animals at postpartum day 9 (P9) (two controls and two challenged) were 
prepared for analysis in light microscopy. For that, brain tissue was processed using 4% 
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paraformaldehyde and embedded in paraffin. Six-_m coronal sections at the fornix region of 
the corpus callosum (15) were selected.  Sections were stained with Luxol fast blue-periodic 
acid Schiff (LFB-PAS, Sigma, St. Louis, Missouri) to allow for evaluation of myelination. 
Brain Ultrastructure (Transmission Electron Microscopy) 
Sections were obtained from brain tissue at P9, (four from pups of challenged dams, 
and four from pups of control dams) for ultrastructral examination. Brain samples were fixed 
in 2% glutaraldehyde, followed by post fixation in 1% osmium tetroxide (OsO4). Staining 
was achieved with 1% aqueous uranyl acetate, followed by dehydration with an ethanol 
gradient. Finally, samples were infiltrated and embedded in pure epoxy. Transmission 
Electron Microscopy (TEM) was then performed (CM12 Philips Electron microscope). 
Samples were examined for pathological changes in the hippocampus region, as well as in 
the cortical areas. This was a pilot observational survey to determine whether there was any 
ultrastructural evidence of structural alterations. 
Statistical Analysis. 
In order to account for the fact that the effects of challenge on littermates are 
clustered within dams, we used a mixed model method (16). The statistical comparison of 
weight gain after 7 days between control and challenged groups was evaluated with a mixed 
effects model with a fixed effect for treatment and a random effect for dam, the latter 
providing adjustment for intra-litter correlation of weight gain. Similar analyses were applied 
to birth weight and percent weight gain after 7 days. Survival analyses were performed using 
Cox regression model without adjusting for dam cluster. Data were analyzed using statistical 
software (SAS Institute, Cary, NC). 
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Results 
C. rectus-mediated Placental Abnormalities and Fetal Brain Inflammation. 
In our previous studies, C. rectus challenge in pregnant mice resulted in a significant 
increase in the percentage of growth restricted fetuses (9). In the present experiments we 
sought to determine whether C. rectus-induced FGR was also associated with histological 
evidence of placental abnormalities and concomitant fetal brain inflammation at E16.5.  
Figure 2.1A shows a typical histological presentation of normal mouse placenta from 
a normal (unchallenged) dam and Figure 2.1B shows a typical placenta from a FGR fetus (C. 
rectus challenged) dam. Both panels show the chorionic plate and the dimensions of the 
labyrinth and junctional zones. It is apparent when comparing Figure 1A to 1B that the width 
of the vascular labyrinth is smaller and the decidual tissue and trophoblast layer occupy a 
larger percent of the tissue cross-sectional dimension. Figure 2.1, also presents the mean ratio 
of junctional zone and total placenta (labyrinth plus junctional zone) for fetal placental tissue 
from challenged and control dams, showing association of C. rectus-mediated FGR and an 
increase of the junctional layer, with a consequent decrease in the relative thickness of the 
labyrinth zone. In the control placental tissues there were scattered inflammatory cells 
present in the decidua of some samples. Figures 2.2B and 2.2D, indicate areas of trophoblast 
invasion of the decidua and apparent vasodilatation of the fetal-placental circulation in the 
junctional zone, associated with inflammatory cell infiltrate. Focal areas of inflammatory cell 
infiltrate were often seen in challenged placentas but were not observed in placentas from 
unchallenged mice. In Figure 2.1A, and Figures 2.2A and 2.2C, the regular aspects and 
proportions of the functional layers can be observed. This pattern was consistently observed 
among the examined samples. It should be noted, however, that the histological analysis of 
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placentas collected from non-runted fetuses from C. rectus challenged dams have not been 
performed. 
Fetal brains were analyzed for TNF- and IFN- mRNA expression by RT-PCR, and 
values for control fetus brains and brains of fetuses from challenged dams are shown in 
Figure 2.3. Although the sample size was small (three brains per group), there was a 
statistically significant 2.8-fold increase in the relative expression of IFN- in fetal brain 
tissues from C. rectus-exposed fetuses as compared to non-challenged controls, P=0.04. The 
2.3-fold increase in TNF- in exposed fetuses as compared to controls was not statistically 
significant with this sample size (four brains per group). Taken together, these data provide 
preliminary observations consistent with the concept that maternal challenge with C. rectus is 
associated with placental inflammation and an increase in fetal brain inflammation, as 
reflected in IFN- mRNA expression. However, the limited numbers of animals used in these 
fetal brain inflammation experiments indicate that the results must be interpreted with 
caution and considered as preliminary observations.  
Effects of C. rectus challenge on pup survival and growth. 
Table 2.2 shows that there was a tendency for fewer surviving pups per litter among 
C. rectus-challenged dams (i.e., 4.6 pups/litter versus 5.1). An increased perinatal mortality 
in challenged dams was anticipated, as runted and abnormal off-spring usually do not survive 
immediately post-partum; however, this difference was not statistically significant. Although 
in previous studies we have demonstrated that C. rectus challenge resulted in fetal growth 
restriction when evaluated at E16.5, the weight of surviving pups within 24 hours of delivery 
was not significantly different for pups from C. rectus challenged dams and control dams 
(Table 2.2). However, the Kaplan-Meier survival function presented in Figure 2.4 shows that 
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not all pups survived the first week post-partum. In unchallenged animals, 92% of all pups 
survived to 1 week of age. Among the C. rectus-challenged animals, despite the normal 
delivery weights, the pup survival rate was 69% which was a statistically significant 3.9–fold 
increase in pup mortality (hazard ratio was 4.1 [95% hazard ratio confidence interval: 1.1–
15.0]). Thus, maternal C. rectus challenge during pregnancy significantly affected newborn 
pup survival within the first week of life.  Among those pups that survived to 1 week of age, 
however, there was no difference in pup size or in rate of growth. In Table 2.3 the pup 
growth for 1-week survivors is presented. It can be seen that survivors double in weight 
within one week and there is no apparent deleterious effect of maternal C. rectus challenge 
on pup growth in terms of rate of weight gain. In fact, pups from the challenged dams that 
survived the first week of life gained 10.4% more weight between P0 and P7 than the 
surviving control pups. However, inflammatory challenges may have more subtle deleterious 
effects on development among survivors. This concept is supported by comparing the brain 
development of pups from challenged or unchallenged dams.  
Figure 2.5A shows hippocampal area and corpus callosum at P9 indicating the region 
selected for observation at the ultrastructural level. Figures 5B through D are representative 
ultrastructural aspects of the normal hippocampal region of control pup brain. These figures 
display the range of normal myelination progression that is occurring at P9 in control mice.  
The effects of maternal C. rectus challenge on pup brain ultrastructural morphology appear in 
Figure 2.6. In contrast to controls, Figure 2.6 shows evidence of myelin sheath splitting with 
the formation of an intra-period line. This feature was commonly observed within the 
hippocampal region and seen in all four brains examined from pups of challenged mice, 
contrasting with the control animals which showed myelin with regular morphology (Figure 
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2.5B and C). The normal myelination process can be seen in Figure 2.5B. In the hippocampal 
region of exposed pups, defects in the myelin sheaths were often accompanied by myelin 
debris and cells showing marked vacuolation (Fig. 2.6B). Examination of pericortical areas 
of brains from pups of challenged animals showed no obvious alterations (Fig. 2.6A). This 
suggested that there was some localization of the structural damage. 
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Discussion 
In humans, maternal infections during pregnancy and attendant inflammatory 
responses are a major cause of preterm birth, which may lead to specific neonatal problems, 
including cerebral white matter damage (periventricular leukomalacia, PVL) and subsequent 
cerebral palsy), respiratory distress syndrome (often leading to chronic lung disease), 
gastrointestinal and vision problems (retinopathy) (3,6,17). Furthermore, increasing evidence 
suggests that the molecular and cellular inflammatory effector pathways that underlie the 
pathogenesis of preterm birth are also involved in both growth restriction and developmental 
problems ranging from respiratory distress to cognitive and learning disabilities (17). 
Intrauterine infection is considered a risk factor for developmental brain injuries in 
childhood. A variety of cytokines known to be toxic to developing brain cells have been 
isolated from mothers or children at risk for developmental disabilities, and these cytokines 
have been proposed as mediators of these injuries. (18) For example, fetal neurological 
tissues are especially susceptible to damage via cytokines, such as IFN-Y, that impair 
development of fetal neurons, and it has been suggested that cytokine exposure at a critical 
period of development may constitute a 'hit-and-run' mechanism for certain nervous system 
disorders that become manifest after a latency period. (19,20) Thus, the threat of maternal 
infectious exposure during pregnancy does not appear to be solely limited to effects on the 
duration of the pregnancy but also potentially to perinatal neurological growth and 
development.  
The present experiments in C. rectus challenged animals demonstrate that this 
infection, which is capable of inducing fetal growth restriction, also induces placental 
structural abnormalities and placental inflammation. The placental inflammation appears as a 
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discrete area of inflammatory cell infiltrate, with a more extensive edema in the decidual 
zone. The decreased thickness of the labyrinth zone suggests that there may be impaired 
vascularization of the placenta. This architectural abnormality has often been interpreted as 
indicative of potential impairment in placentation and nutrient flow to the fetus since, in the 
mouse, the exchange of respiratory gases, nutrients, and wastes takes place in the labyrinth 
layer between fetal blood vessels, lined by endothelial cells, and maternal blood sinuses, 
lined by trophoblast cells. (21,22) The uterine bed undergoes remarkable changes during 
pregnancy, including proliferation and decidualization of the uterine stroma and remodeling 
and angiogenesis of the maternal vasculature. Fetal-derived trophoblast giant cells invade 
into the uterus where they gain access to the maternal blood circulation to ensure sufficient 
nutrient supply of the embryo. Trophoblast giant cells have the intrinsic capacity to attract 
and increase blood flow, affecting endothelial cell migration and vascularization through the 
production of the hormones proliferin and proliferin-related protein, and gradually displace 
the vascular endothelium, replace the normal vascular endothelium, and acquire a pseudo-
endothelial shape, resulting in the formation of canals entirely lined by trophoblast cells. 
(23)  
During pregnancy the placenta is not only exposed to the maternal immune system, 
but also to microorganisms, so it is thought that the trophoblast at the maternal-fetal interface 
also actively participates in preventing allorecognition (24), and in the control of pathogens 
that may compromise the fetal well-being (25). Thus, the trophoblast may be acting as a 
pregnancy-specific component of the innate immune system. The presented histological 
findings showing invasion of trophoblasts in the decidua, thus increasing the dimensions of 
this area where inflammatory cellular infiltrate could be found, are supportive of the 
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trophoblasts’ protective function that involves organizing the immune response to bacterial 
infection at the maternal - placental interface. 
Several studies have linked these histological findings to changes in vascular and 
endothelial structure, as well as alterations in vascular and endothelial growth factor 
expression (26,27). The placental samples and more detailed histological findings are the 
subject of an ongoing separate study that correlates placental pathology with data using gene 
expression microarrays.  Nonetheless, the histological presentation and presence of up-
regulated inflammatory genes as determined by microarray analyses (data not shown) are 
consistent with reports of human placental biopsy findings, which have commonly reported 
placental areas of focal necrosis and inflammation with FGR deliveries.   
Subcutaneous challenge of pregnant dams with C. rectus also induces fetal brain 
increases in pro-inflammatory cytokines. Previous studies have shown that the administration 
of TNF- and IFN- to pregnant mice increases fetal abortion and fetal abnormalities, such 
as reduction of fetal weight and interference in eye development (28,29). IFN-Y is a potent 
mediator of neuronal oxidative stress and can mediate neuronal apoptosis and impair 
myelination (30). It modulates cell death by sensitizing cells to killing by numerous pro-
apoptotic stimuli (31). Astrocytes and microglia produce TNF-L in the central nervous 
system, and its effects on oligodendrocytes have also been extensively studied (32,33). 
Tumor necrosis factor-alpha can decrease the expression of oligodendrocyte specific proteins 
and induce apoptosis of these cells (34). In addition, TNF-L and IFN-Z have been shown to 
have a synergetic effect on cell death in human oligodendroglial cell lines (35). Thus, the 
finding of increased IFN- and TNF-L in the fetal brain as a consequence of C. rectus 
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mediated placental inflammation suggests the potential for perinatal neurological 
impairment.  
The mechanisms of fetal brain damage due to intrauterine infection or inflammation 
have been investigated using various animal models. In rats, maternal injection of LPS 
induced expression of the proinflammatory cytokines interleukin-1 (IL-1N) and TNF-L in the 
fetal brains, as well as decreases in myelin basic protein (36). Autopsy specimens from 
extremely low birth weight children with PVL, a condition characterized by focal or diffuse 
lesions within cerebral white matter, showed evidence of TNF-L overexpression by 
microglial cells (37). The presence of proinflammatory cytokines within PVL lesions is 
supportive of a relationship between PVL and intrauterine infection, although this could 
potentially be a secondary effect of ischemia or other insults (38,39). Recently, LPS has been 
suggested as an important mediator of injury to oligodendrocytes (40). Also, P. gingivalis 
LPS has been demonstrated to participate in the pathogenesis of central nervous system 
inflammatory disorders (41); white matter rarefaction, hypomyelination and oligodendrocyte 
injury were observed after intracerebral injection of LPS in 5-day-old rat pups (42).  
In the present study, instead of LPS maternal or intracerebral injection, we observed 
the effects of subcutaneous maternal challenge with C. rectus on the brains of 9-day-old 
pups. Cellular and myelin alterations were common findings in the hippocampus region, 
which is indicative of cellular damage leading to myelination defects. Myelination is an 
essential event for the final maturation of central white matter tracts. It remains to be 
determined whether the observed myelin defects reflects impaired myelin formation by the 
oligodendrocytes or is related to an inflammatory demyelination process mediated by 
astroglial cells.  
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This study also provides the first evidence that C. rectus challenged mothers give rise 
to offspring that are at greater risk for morbidity and mortality. We do not know whether this 
trait is unique to C. rectus, as the effects of other oral organisms such as P. gingivalis on 
neonatal morbidity or mortality have not been studied. The observation that there are fewer 
newborn pups of C. rectus-challenged dams (albeit not statistically significant) is consistent 
with the anticipated rate of fetal demise as a consequence of challenge (9). There was a 3.9-
fold increase in neonatal fatalities within the first week of life among exposed pups. This 
increase in mortality may be mediated by differences in maternal fostering, since in these 
experiments newborn pups were fostered by their own mother. For example, mothers 
challenged with C. rectus may have impaired lactation or may serve as a potential reservoir 
of infectious or inflammatory stress. It is interesting to note, however, that the surviving pups 
of challenged dams gained 10.4% more weight within the first week of life than the controls. 
More studies on the cause of this higher weight gain and its possible implications are 
underway. Interestingly, these pups, although they appear normal and healthy, show 
histological evidence of neurological damage at day 9. This observation suggests that all the 
fetuses were affected by the infection, albeit with various degrees of severity, regardless of 
whether they suffered from fetal growth restriction. In humans, elevated levels of 
inflammatory cytokines like TNF-alpha, have also been observed to associate with increased 
risk of preterm delivery, chorioamnionitis and fetal morbidity including encephalopathy (43, 
44).  
In conclusion, these results show that a distant intra-chamber challenge of pregnant 
mice with the periopathogen C. rectus induces placental structural abnormalities and 
placental inflammation as well as signs of inflammation in fetal brains 9 days post-infection.  
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In addition, while most of the pups born to the challenged dams are viable and appear 
normal, about a third do not survive the first week of life, and signs of structural damage 
were observed in the hyppocampal region of the brains of 9-day old pups.  These findings 
also suggest the potential importance of examining the role of nerve growth factors (NGF) as 
mediators in myelination defects, since increased NGF levels have been shown to be 
involved in the differentiation of oligodendrocytes from precursor cells (45), especially 
brain-derived neurotrophic factor (BDNF), the second member of the neurotrophin family to 
be identified and cloned in 1989 (46). BDNF can be one of the factors mediating cross talk 
between the immune and nervous system, since neurons are the principal source of BDNF 
and inflammatory cells are also important source of this neurotrophic factor. Currently, there 
is no information about BDNF mediating cross talk.  Future research could include 
identifying the role of BDNF and conducting, neurobehavioral studies on the pups in order to 
examine for possible long-term neurological impairment in the pups of maternal C. rectus-
challenged mice. 
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Figure 2.1. Placental structure in mice at day 16.5 of pregnancy. (A, B) The different 
functional layers of the mouse placenta are shown where we can identify junctional region 
(jz) and labyrinth (l). Differences in placental cross sectional area and the relative proportions 
of the different functional areas are presented. H&E; bar =200 _m. ( C ) Ratio between the 
zones junctional and labyrinth + junctional (total placenta) demonstrating that junctional 
zone is significantly increased in the challenged placenta. 
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Figure 2.2. Placenta - Hematoxylin and Eosin staining. (A) and  (C) show labyrinth (l) and 
decidua (d) with trophoblast giant cells (t) presenting normal aspect; maternal red blood cells 
are indicated (*). In the challenged mice (B, D) a more extensive junctional zone can be 
observed with a greater number of blood vessels (*) surrounded by trophoblats (arrowheads) 
and inflammatory infiltrate. At higher magnification (D) note inflammatory cell infiltrate in 
the vessels (arrows) and the periendovascular trophoblast cells (arrowheads) associated with 
maternal blood vessels. Bar= 50 _m
75
Figure 2.3. Fetal brain expression of TNF and IFN, as determined by RT-PCR in 
fetal growth restricted fetuses from C. rectus-challenged dams and fetuses from control 
dams on day E16.5. Bars represent the standard error. TNF-: N=4 fetuses per group; IFN-
: N=3 fetuses per group. *Statistical significant difference foe IFN-.
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Figure 2.4. Kaplan-Meier one-week survival curve of live birth pups from unchallenged 
dams and C. rectus challenged dams. 
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Figure 2.5. (A) Hippocampus area from a 9-days (P9) mouse representing the area studied. 
Corpus callosum (arrow); hippocampal area (H); LFB/PAS staining. (B, C, D) Electron 
micrographs of axons from control pups (P9) brain; (B) shows detail of ensheathing process 
with oligodendrocytes processes wrapping the axon (arrow). (C and D) Myelin (arrowhead), 
large ensheathed axons (arrows). M= mitochondria; bar=50 _m. 
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Figure 2.6. Electron micrographs of axons from the brains of challenged pups (P9). (A) 
Regular myelin structure in the cortical brain area. (B,C, D) Hippocampal brain area. (B) 
Exhibits brain cells with a great number of cytoplasmatic vacuoles (*)  and cellular debris 
surrounded by essentially empty space reflecting cellular damage. In C and D, myelination 
defects can be observed with myelin vacuolation and also myelin splitting (arrows).   
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Table 2.2. Effect of C. rectus Challenge on Number and Weight of Pups.  
 N Dams N Pups 
Mean N Live 
Pups per Litter (SD) 
Mean Pup  
Birth Weight (g) (SD) 
Control 8 36 5.14 (0.9) 1.41 (0.16) 
Challenged 8 32 4.57 (2.4) 1.42 (0.17) 
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Table 2.3. Birth Weight and Growth of Pups Surviving the First Week of Life 
(postnatal day P0 to P7).  
 
Control Challenged
P
Value 
N pups survived 33 22  
Mean birth weight 
(g) (SE) 
1.4        
(0.1) 
1.5         
(0.1) 
0.5739 
Mean weight gain 
(g) (P0 to P7) (SE) 
2.9        
(0.1) 
3.2         
(0.1) 
0.1137 
Mean % weight gain 
(P0 to 7) (SE)  
201.7   
(9.3) 
216.2    
(10.4) 
0.3183 
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Introduction 
Maternal oral infection, caused by bacteria such as C. rectus or P gingivalis, has 
been implicated as a potential source of placental and fetal infectious and inflammatory 
challenge that increases the relative risk for preterm delivery and growth restriction (1-4).  
Intrauterine growth restriction (IUGR) has also been reported in various animal models using 
infections with oral organisms (5-9). We investigated in a mouse model whether maternal 
infection with C. rectus alters the expression of genes important for placental growth and 
development that could contribute to the observed IUGR. Moreover, since promoter 
hypermethylation is implicated with gene silencing we assessed whether infection mediates 
changes in the methylation patterns of these genes. Using the placenta of infected IUGR 
mice, we found down-regulation of many key genes important for placental/fetal growth, 
such as Igf2 and that the promoter of Igf2 was significantly hypermethylated. These results 
indicate that maternal infection can result in alterations in placental epigenetic methylation 
patterns that may have the potential to affect the well-being of the offspring.   
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Results and Discussion 
 We challenged pregnant dams at E7.5 with 108 CFU live C. rectus strain 314 and 
sacrificed at E16.5 to assess fetal growth and harvest placental tissues. In the present 
experiments we used a different strain of C. rectus than our previous publications (7), but 
found similar results in that maternal C. rectus infection impairs fetal growth. IUGR, 
(defined at E16.5 as fetal weight of less than two standard deviations below the mean of 
unchallenged fetuses) was observed in 22.8% of the fetuses of challenged litters compared to 
2.7% IUGR from unchallenged dams, p<0.01. Fetal weights and lengths are provided in 
Table 3.1. Maternal infection also resulted in placental translocation of C. rectus, as reflected 
by the nested PCR detection in 46.7% of IUGR fetuses (Fig. 3.1). Interestingly, although 
infection induced IUGR, the placental weight was not significantly altered (Table 3.1). 
Nevertheless, there were structural alterations within the placental layers with a relative 
decrease in the labyrinth and a concomitant increase in the decidual layer (Fig. 3.2).   
 To identify molecular pathways associated with this process we compared the whole 
placental transcriptome of C. rectus-challenged IUGR placentas to that of unchallenged 
placentas to screen for differentially expressed genes. We found 74 genes that were 
differentially expressed by SAM analysis. Among these genes there were only 9 that were 
significantly up-regulated, whereas 65 genes were down-regulated, including Desrt (q< 
0.0001), Pgf (q= 0.0456) and Gal (q< 0.0001) (Fig. 3.3a). Thus, the effects of infection on 
gene expression were predominantly suppressive (88%) rather than stimulatory (12%) (Table 
3.2). The suppression of multiple transcripts raises the possibility that infection might impair 
fetal growth by suppressing placental growth factor expression in a manner that is analogous 
to the effects of gene knockout experiments that impair fetal growth, as reviewed by Rousant 
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and Cross (10). Table 3.3 compiles a list of some of the genes identified by murine knockout 
experiments to be critical for placental growth, development and function (10,11), which 
were also present on our arrays. This table lists the specific placental abnormality associated 
with each gene knockout and the fold decrease in gene expression as a result of C. rectus 
challenge. It is interesting to note that the 12 genes on our arrays, known to be essential for 
placental growth, each showed a trend for decreased expression. Considering the group of 12 
genes as a single cluster the group was significantly depressed by an overall mean of 57%, 
p=0.012 (one-sided). One gene from this group, Igf2 was depressed 1.92-fold in C. rectus 
challenged placentas (Table 3.3). Quantitative PCR for Igf2 expression revealed a significant 
2.3-fold decrease (p=0.0005) in placentas from IUGR fetuses confirming this array finding 
(Fig. 3.3b). Interestingly, mouse fetuses in which the Igf2 gene has been completely deleted 
show a 31% decrease in birth weight compared to their wild-type littermates (12). This 
decrease in fetal weight at birth is similar to the 27% reduction in weight at E16.5 we 
observed. Furthermore, in humans with IUGR, placental tissues display a significant 2.1 and 
2.6 fold decreased expression of IGF1 and IGF2 respectively (13). Thus, C. rectus infection 
suppresses Igf2 expression and this finding represents the first report of an infection-
mediated placental suppression of a growth factor that is critical to both placental and 
somatic fetal growth. 
 Further array analysis revealed that several known imprinted genes show a tendency to be 
down-regulated (data not shown), including genes such as Ascl2, Pparg and Igf2 (Table 3.3) 
that are also related to placental/fetal development and growth. Although the process of gene 
imprinting and methylation is genetically controlled, various environmental factors are 
known to epigenetically modify gene methylation patterns often resulting in a permanent 
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silencing of their expression (14). The observation that the expression of several imprinted 
genes is down-regulated in placentas from infected IUGR fetuses, led us to believe that 
infection may be an important factor influencing epigenetic gene regulation in the placenta. 
This idea is also strengthened by the array finding of a 1.72-fold increase in cytosine DNA 
methyltransferase expression following C. rectus challenge, suggesting the possible 
increased activation of epigenetic methylation pathways as a consequence of infectious 
exposure. 
 Since the promoter region P0 of Igf2 controls the expression of this gene in the placenta 
(15), our hypothesis was that the observed suppression of Igf2 expression may be the result 
of epigenetic hypermethylation of CpG sites in P0.  To test this hypothesis, we applied the 
bisulfite sequencing method to quantify placental DNA methylation in the Igf2 P0 that is 
within the differentially methylated region 0 (DMR0). 
Figure 3.4a shows the location of the CpG islands and the differentially methylated 
regions of the Igf2 gene, as well as the location of the 4 promoters. The positions of the 16 
CpG dinucleotides within P0 are illustrated in Figure 3.4b. We sequenced a total of 390 
clones using 3 amplicon regions (Fig 3.4b) to evaluate methylation levels for each CpG loci. 
Since P0 is maternally imprinted there was methylation across this region in unchallenged 
placental tissues (Fig 3.4c,d). However, there was an overall 10.3% increase (p<0.0001) in 
CpG methylation across the entire P0 region in placental DNA from infected IUGR 
placentas. There was a general trend for increased methylation in 11 of the 16 CpG sites 
following C. rectus challenge with six sites demonstrating a CpG hypermethylation greater 
than 10% relative to unchallenged (Fig. 3.4c). This hypermethylation was statistically 
significant (p<0.05) at 4 CpG sites (Fig. 3.4c,d). At CpG loci 7845 there was a 1.89-fold 
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increase in methylation relative to control [OR=1.89 (95% CI, 1.03-3.45)]; at site 7869 a 
2.51-fold increase (95% CI, 1.04-6.07); at site 8461 a 1.79 fold increase (95%CI, 1.07-2.98) 
and at site 8472 a 2.24–fold increase (95% CI, 1.07-4.71). It is interesting to note that the 
hypermethylated regions are clustered within the P0. The concordance of the 
hypermethylation patterns in each region was very high. For example, analysis of amplicon 1 
showed that the overall concordance for site methylation between CpG 7845 and 7869 was 
76.7% (p<0.0001). Similarly analysis of amplicon 3 revealed that the concordance for 
methylation at the CpG site 8461 and 8472 was 89.4% (p<0.0001). Thus, hypermethylation 
appears to be a site-directed process rather than a non-specific increased methylation across 
the entire P0.  
These findings indicate that bacterial infection, which was associated with impaired 
Igf2 expression, is also associated with hypermethylation of the P0 at four loci with a site-
specific odds ratio for hypermethylation ranging from 1.79-2.51 (Fig. 3.4d). To our 
knowledge, this is the first documentation of infection-induced epigenetic modification of 
methylation patterns of imprinted genes.  
Although previous investigations have shown that methylation of the Igf2 promoter is 
associated with gene silencing and the importance of the H19 locus (16,17), it remains to be 
seen whether infection-mediated P0 methylation is functionally related to the observed 
suppression of Igf2 expression. It is also interesting to note that the region of 
hypermethylation at the CpG site 8461 and 8472 contains a Sp1 binding element, but the 
effects of bacterial infection-induced hypermethylation on transcriptional regulation remain 
to be elucidated. 
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Furthermore, it is not known whether infection induced DNA hyper-methylation is 
restricted to Igf2 or extends to other imprinted gene targets or other genes with potential CpG 
methylation loci, as recently described (18). The observation from our arrays that many 
imprinted genes are down-regulated following infectious exposure, including Gnas, Peg3, 
Ascl2, Igf2 and Pparg, raises the important question as to whether there is a more generalized 
effect on multiple genes via this hypermethylation mechanism. Consistent with our bacterial 
infection- induced murine model of IUGR, array data from human IUGR placental tissues 
also demonstrated down-regulation of several imprinted genes including IGF2 (2.6-fold), 
PEG3 and GNAS (13). 
Another important question is whether hypermethylation is mediated directly by the 
bacteria or by the host inflammatory response. C. rectus is known to invade placental tissues 
(Fig. 3.1) and to also be an intracellular pathogen (19). Finally, it remains to be seen as to 
whether the observed placental DNA hypermethylation also extends to the fetus where it may 
have the potential to remain for the lifetime of the off-spring as a somatic epigenetic 
modification. This possibility has far-reaching implications with regards to the role of 
maternal infection as a modifier of the health of the off-spring. 
There are well-established linkages in humans between intrauterine infection, growth 
restriction and permanent disability in the off-spring (20). Extremely low birth weight is 
associated with a dramatic increase in rates of cerebral palsy, asthma, IQ below 85 and other 
disabilities in children (21). Low birth weight also increases the risk for diseases that do not 
become evident until adulthood, such as cardiovascular disease and Type 2 diabetes (22,23). 
This new finding provides impetus for future experiments to determine whether maternal 
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bacterial infection may induce placental and/or fetal epigenetic DNA methylation that may 
result in a permanent alteration in the phenotype of the off-spring.  
In conclusion, the data provide new evidence that infection with oral bacteria has the 
capacity to suppress placental growth factor expression and impair placental structural 
architecture. Moreover, infection induces placental DNA hypermethylation of the Igf2 P0. 
Further research will be needed to determine whether oral infection has similar effects in 
humans. However, this organism is a commensal inhabitant of the oral cavity of humans and 
during pregnancy a fetal IgM response to C. rectus is relatively common, occurring in 27.8% 
of all pregnant women and in 52.6% of those infants at less than 32 weeks gestation, p=0.01 
(24). Thus, the potential effects of maternal oral infection on inducing abnormal placental 
and/or fetal imprinting patterns merits further study. 
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Methods 
Mouse Infection Model  
All mouse experiments were carried out under the approval of the UNC Institutional 
Animal Care and Use Committee and have been described in detail previously (5,7). A 
stainless steel coil (1 cm x 0.4 cm) was surgically implanted subcutaneously in adult BALB/c 
mice. After healing, mice were mated overnight and pregnant dams received an intrachamber 
injection of 100 µl of 109 CFU/mL live C. rectus or PBS at E7.5. Mice were sacrificed at 
E16.5 and fetuses (n=144 from 27 unchallenged dams and n=193 from 32 challenged dams) 
and placenta tissues (n=106 from 19 unchallenged dams and n=105 from 19 challenged 
dams) were collected. We measured the weight and crown-rump length and we performed 
statistical analysis using a mixed model method (25) in order to account for the fact that 
effects of challenge on littermates are clustered within dams. 
Bacterial Culture  
We cultured C. rectus strain 314 under anaerobic conditions at 37° C on PRAS ETSA 
plates (Anaerobe Systems AS-546). Bacteria were used at their log phase of growth. 
Nested-PCR Analysis for Detection of C. rectus 
We extracted genomic DNA from placenta tissues using the DNeasy kit (Qiagen) 
according to the manufacturer’s instructions. Nested PCR was performed using the 
HotStarTaq DNA Polymerase Kit (Qiagen). For the fist reaction we used 1 _g of DNA in a 
final 25 _L PCR reaction mixture containing 100 _M dNTPs, 1 _M of universal 
Campylobacter rRNA primers, 2.5 units of HotStar Taq polymerase, 10 PCR buffer and 5
Q-solution. For the second reaction 1 _L of the universal reaction was used in 50 _L of 
reaction mixture containing 100 _M dNTPs, 1 _M of C. rectus primers, 2.5 units of HotStar 
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Taq polymerase, 10 PCR buffer and 5 Q-solution. The primer pairs and PCR conditions 
are provided in Tables 3.4 and 3.5. 
Microarray Analysis 
Pooled RNA from 15 placentas from 8 different unchallenged dams was compared to 
a reference RNA (Ambion) in triplicates. RNA from 4 challenged dams from IUGR 
placentas were individually compared with the same reference RNA giving a total of 7 
arrays. Specifically, we isolated total RNA from placental tissues using the RNeasy kit 
(Qiagen) following the manufacturer’s protocol. We then amplified and fluorescently labeled 
the mRNA using the Agilent Low RNA Input Fluorescent Linear Amplification kit (Agilent 
Techologies) and then hybridized them on an Agilent Oligo array (G4121A). We collected 
the raw data using the Feature Extraction software (Agilent Technologies) and normalized 
them applying the LOWESS normalization. Finally, we analyzed the data using the 
Permutation test at a false positive discovery rate of 0.0486, using the Significance Analysis 
of Microarrays software (SAM) v.2.23 (Stanford University, CA) (26). To determine whether 
placental/fetal growth and development genes were significantly down-regulated as a cluster 
of 12 genes we used the relative gene expression for unchallenged or challenged IUGR 
placentas using the O’brien non-parametric rank-sum test for uniformity of the multivariate 
end-point (27).  
Quantitative RT-PCR for Igf2 
We isolated total RNA from placental tissues (6 unchallenged and 6 challenged with 
IUGR) using the RNeasy Mini Kit (Qiagen) following the manufacturer’s protocol. We then 
synthesized cDNA from 2 µg of total RNA using the Omniscript Kit (Qiagen) and oligo-dT 
primers. We carried out Real Time PCR using 1 µL cDNA, TaqMan Universal PCR mix 
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with no amperase and 20X primer (Applied Biosystems), in a 7000 Sequence Detection 
System apparatus (Applied Biosystems). Reactions were performed 2 independent times in 
triplicates. We evaluated the results using the ABI Prism software (Applied Biosystems). 
Data were normalized to GAPDH expression. We performed statistical analysis using one 
way ANOVA. The Igf2 primers and PCR conditions are provided in Tables 3.4 and 3.5 
DNA Methylation Analysis 
We extracted genomic DNA from control and IUGR placentas using the DNeasy kit 
(Qiagen). Following DNA isolation, sodium bisulfite modification of DNA was performed 
using a protocol adapted from Grunau et al (28) as previously described (29). We divided the 
P0 region included in the DMR0 region into 3 potential amplicons and conducted a bisulfite 
based PCR using the primers listed in Table 3.4. We then cloned the PCR products into the 
pGEM-T Easy vector (Promega A1380) and PCR amplified each clone with standard Sp6 
and T7 primers (Tables 3.4 and 3.5). Fifty to 90 clones were finally sequenced for each 
amplicon region for unchallenged and challenged groups using the primer Sp6. To test the 
null hypothesis that there was no difference in the methylation rate between C. rectus-
challenged with IUGR group and unchallenged group, we applied a logistic regression model 
for each loci using empirical sandwich variance estimation taking into account the correlation 
of clones within each placenta sample and the overdispersion (30).  
Morphometric Analysis 
We fixed placentas in 4% paraformaldehyde, bisected sagittally, processed and 
embedded in paraffin. Sections (5 µm) were stained using standard hematoxylin and eosin 
(H&E) protocols. The areas (in mm2) of the various placental zones were calculated using the 
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“Image J” software (http://rsb.info.nih.gov/ij/). We performed statistical analysis using one 
way ANOVA.  
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Figure 3.1. Translocation of C. rectus to the placenta at E16.5. Nested PCR for detection 
of C. rectus in placenta at E16.5. Although, dams were infected with an intrachamber 
injection with C. rectus, 7 out of 15 placenta from challenged with IUGR fetuses had a 
positive signal. Primers and conditions present in methods and supplementary Tables 2 and 
3. PC positive control for C. rectus spiked placenta.   
598 bp
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Figure 3.2. C. rectus infection induces structural abnormalities in the placenta. H&E 
staining from unchallenged (a, c) and challenged with IUGR (b, d) placentas. In the IUGR 
challenged samples there is a significant relative decrease in the labyrinth area with a 
concomitant increase in the decidua. The spongiotrophoblast layer is not altered. The 
labyrinth/(spongiotrophoblast+ decidua) ratio is significantly decreased (e). Statistical 
analysis was performed with 1-way ANOVA, * p<0.001, **p=0.04, n number of samples. (c) 
and (d) are histological sections indicated by rectangles in figures (a) and (b) with high 
power magnification. Scale bar in (a) and (b) 500 _m and in (c) and (d) 125 _m. L labyrinth, 
S spongiotrophoblast layer, Sp spongiotrophoblast cells, Gl glycogen cells, D decidua. 
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Figure 3.3. Differential expression of genes in the placenta at E16.5 after C. rectus 
challenge. (a) Shows the distribution of genes that were significantly altered in the 
challenged with IUGR placenta compared to the unchallenged placenta. Genes below the 
middle green line are down-regulated whereas genes above this line are up-regulated. The 
other two green lines represent the threshold of 2-fold difference in expression. These results 
were obtained by analyzing 7 arrays (details in methods). From the 74 genes that were 
differentially expressed, only 9 genes were significantly up-regulated, whereas 65 genes were 
down-regulated. Thus, the effects of infection on gene expression were predominantly 
suppressive (88%) rather than stimulatory (12%). The fold change of these genes ranged 
from 1.68-3.34. (b) Quantitative RT-PCR analysis for Igf2. The relative expression of Igf2 
from unchallenged (red) and challenged with IUGR (blue) placenta were compared. 
Reactions were performed 2 independent times in triplicates. Mean values and error bars are 
presented. Statistical analysis was performed with 1-way ANOVA,*p=0.005, n number of 
samples (details in methods). There is a significant 2.3 fold decrease in the relative 
expression of Igf2 in the challenged placenta at E16.5. 
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Figure 3.4. C. rectus infection induces hypermethylation of the P0 promoter of Igf2 in 
the placenta. DNA from unchallenged and challenged with IUGR placenta were bisulfite 
treated and sequenced (details in methods). (a) Presents the location of the CpG islands and 
the differentially methylated regions (DMR) of the Igf2 gene, as well as the location of the 4 
promoters (P0, P1, P2, P3). (b) Shows the 16 CpG dinoucleotides (vertical gray lines) within 
the P0, which are also part of the DMR0. This DNA fragment extends from site 7782 to 8512 
(GenBank Accession # U71085).  To facilitate the sequencing process we divided this region 
in 3 areas (amplicons 1-3). (c) For each CpG loci 50-90 clones were sequenced per 
experimental group giving a total of 390 clones. The six red vertical lines represent the CpG 
sites that were hypermethylated by more than 10% after C. rectus infection. * shows the CpG 
sites where hypermethylation was statistically significant (p<0.05). (d) Depicts the 
percentage of methylation at each of the CpG sites from the unchallenged (red) and 
challenged with IUGR (blue) placenta. Mean % methylation and error bars are presented. 
Statistical analysis can be found in methods. * CpG sites where hypermethylation was 
statistically significant (p<0.05). OR odds ratio, parenthesis includes the confidence interval. 
Four CpG sites were significantly hypermethylated (7845, 7869, 8461 and 8472) and these 
sites appear to be clustered. 
102
Table 3.1. C. rectus infection impairs fetal growth. Pregnant mice were challenged with C. 
rectus or saline at E7.5 and sacrificed at E16.5. IUGR was defined as fetal weight of less than 
two standard deviations below the mean of unchallenged fetuses. This table summarizes the 
effects of C. rectus challenge on fetal weight and length, and placental weight. Statistical 
analysis was performed using a mixed model method to address for clustering (see methods 
for details) comparing each group with the unchallenged group, *p<0.001. Mean values ± 
standard errors and number of samples are included. C. rectus infection significantly reduced 
fetal weight and fetal length, but did not alter  
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Table 3.2. C. rectus infection significantly alters the expression of 74 genes in the 
placenta at E16.5 (Microarray Data). 
 
Up-regulated genes 
Gene Name Fold Change q-value(%) 
NM_011166 3.34 0.00 
NM_133709 2.15 0.00 
AK030707 1.73 0.00 
NM_021394 1.83 0.00 
NM_008221 1.73 0.00 
NM_008219 1.81 3.21 
NM_016696 1.56 3.21 
AK088732 1.98 4.86 
NM_025722 1.68 4.86 
Down-regulated genes 
Gene Name Fold Change q-value(%) 
NM_031160 0.33 0.00 
BU555670 0.35 0.00 
AK005254 0.30 0.00 
AK007181 0.34 0.00 
BQ944428 0.38 0.00 
NM_010253 0.42 0.00 
BC006669 0.47 0.00 
BU851290 0.43 0.00 
BC021465 0.30 0.00 
AK081177 0.46 0.00 
NM_018803 0.46 0.00 
AK005784 0.49 0.00 
NM_133243 0.41 0.00 
NM_021417 0.41 0.00 
NM_023598 0.44 0.00 
NM_133779 0.53 0.00 
X51959 0.49 0.00 
NM_011172 0.49 0.00 
NM_009872 0.41 0.00 
AK006745 0.53 0.00 
NM_011174.2 0.56 0.00 
NM_027205 0.60 0.00 
X56974 0.38 0.00 
NM_013774 0.48 0.00 
AK005678 0.52 0.00 
AK033376 0.48 0.00 
BC006965 0.41 0.00 
BB808820 0.59 0.00 
AK018447 0.54 0.00 
NM_021424 0.59 0.00 
AK011828  0.51 0.00 
BU938226  0.45 0.00 
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NM_019962 0.63 0.00 
NM_147062.1 0.65 0.00 
NM_015738 0.58 0.00 
NM_008369 0.58 0.00 
AK042403 0.60 0.00 
NM_007738 0.58 0.00 
AJ428066 0.41 0.00 
NM_147101.1 0.53 0.00 
AF357471 0.61 1.80 
NM_031261 0.63 1.80 
AK038658 0.59 1.80 
BC019819 0.56 1.80 
NM_009392 0.51 1.80 
NM_022012 0.58 1.80 
NM_008172 0.59 1.80 
AK077415 0.62 3.21 
BC021945 0.64 3.21 
NM_010092 0.58 3.21 
AK082521 0.62 3.21 
AK009780 0.64 3.21 
NM_022982 0.65 3.21 
AK089462 0.60 3.21 
AK090166 0.53 3.21 
AK017902 0.50 3.21 
AW557161 0.58 3.21 
NM_170759.1 0.56 4.15 
ENSMUST81 0.60 4.56 
NM_011971 0.66 4.56 
NM_008827 0.64 4.56 
AK054264 0.68 4.56 
BC019382 0.55 4.56 
NM_008589 0.59 4.86 
BY121702 0.56 4.86 
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Table 3.3. C. rectus infection down-regulates the expression of genes important for 
fetal/placental development at E16.5. 
Placental Function Gene Gene Product Fold 
Decrease 
Spongiotrophoblast 
maintenance 
Ascl2* 
(Mash2) bHLH transcription factor 1.96 
Regulation of fetal-placental 
growth Igf2* Insulin-like growth factor 2 1.92 
Chorioallantoic branching and 
labyrinthine development Gcm1 Transcription factor 1.85 
Vascularization of labyrinth Esx1 Homeobox transcription factor 1.69 
Chorioallantoic branching and 
labyrinthine development Pparg* Nuclear hormone receptor 1. 67 
Chorioallantoic branching and 
labyrinthine development Dlx3 Homeobox transcription factor 1. 59 
Trophoblast giant cell 
differentiation Hand1 bHLH transcription factor 1.51 
Chorioallantoic branching and 
labyrinthine development Pdgfra 
Platelet-derived growth factor 
receptor L 1.48 
Nutrient transport across 
labyrinth 
Gjb2 
(Cx26) Connexin, gap junction protein 1. 41 
Trophoblast lineage 
development Fgf4 Fibroblast growth factor 4 1.31 
Ectoplacental cone function Ets2 Ets domain transcription factor 1.29 
Chorioallantoic branching and 
labyrinthine development Fzd5 Frizzled 5, Wnt receptor 1.25 
* Genes that are known to be imprinted. 
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Table 3.4. Primer sequences. 
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Table 3.5. PCR conditions. 
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Discussion 
 
In recent years, there is increasing evidence that periodontal disease is associated with 
a higher risk for pregnancy complications. However, little is known about the mechanisms 
that underlie this association. While the development and function of the placenta are critical 
for normal fetal growth, the effects of periodontal disease on these processes have not been 
investigated. The overall purpose of this study was to evaluate the effects of periodontal 
disease on the placenta that may contribute to the observed adverse pregnancy outcomes. 
Specifically, using a subcutaneous infection mouse model, we sought to determine whether 
maternal C. rectus infection leads to alterations in the structure and gene expression of the 
placenta that may contribute to IUGR. Moreover, we investigated possible molecular 
mechanisms that may have played a role in these processes. 
The study of human placenta poses some restrictions since the placenta can be 
examined in-depth only at the time of delivery. However, several experimental animal 
models have proven to be a valuable source of information of placental biology. Among 
those, mouse models are very common and offer several advantages: a) the gestation time is 
short and each litter consists of several fetuses/placentas which increases the potential sample 
size studied, b) the placenta can be examined in depth at different time-points of gestation, c) 
each fetus has its own placenta, which allows for direct association of each placenta with its 
fetal phenotype, and d) our knowledge of placental biology is more comprehensive in mice 
than in humans due to the large volume of mouse models available.  
Of course, this raises the question as to whether mice data can relate to human. 
Definitely, the study of human placenta cannot be replaced by studies in mice. However, 
there are several reasons that suggest that information from pregnant mice may give valuable 
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insight about the biology of the human placenta and the adverse pregnancy outcomes. 
Specifically, although different, the mouse and human placenta show considerable 
structural/functional similarities (Fig.4.1) (1). The outer layer of the mouse placenta is 
composed of trophoblast giant cells that mediate implantation and invasion into the uterus. 
The latter behavior is similar to that of invasive extravillous cytotrophoblast cells in humans. 
Also, the labyrinth layer of the mouse placenta is completely analogous in function to the 
chorionic villi of the human placenta. In both the human and rodent placenta, the villi are 
covered by syncytiotrophoblast that lie in direct contact with maternal blood. Moreover, 
many key regulatory molecules, such as   Mash2, Hand1, Gcm1, Hgf and c-Met, involved in 
the various mouse placental subtypes are expressed and functional in the analogous cell types 
in humans (2-6).Finally, in humans, IUGR and pre-eclampsia are considered to be due to 
distinct pathologies that affect different placental components. Pre-eclampsia is often 
associated with the defective differentiation and invasion of extravillous cytotrophoblast 
cells, while in severe cases of early-onset IUGR (7) the placenta is typically characterized by 
reduced branching of the chorionic villi and the underlying vasculature. Similar placental 
abnormalities are observed in mutant mice that do not express genes of distinct genetic 
pathways. Hence, it is likely that these different human placental pathologies have distinct 
underlying molecular abnormalities, similar to those observed in mice.  
 Since a periodontitis model cannot by applied in mice, in order to assess systemic 
effects of periodontal disease we infected pregnant dams with the periodontal pathogen C. 
rectus by injecting the bacteria in a subcutaneous chamber. This model has the disadvantage 
that the infection does not occur in periodontal tissues and it does not take into account that 
periodontal disease is induced by a mixed infection and not only by one pathogen. However, 
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the subcutaneous chamber model provides the basis of a distant infection, which allows for 
bacteria to disseminate systemically, similar to what happens during periodontal disease. 
Moreover, although periodontal infections are mixed infections, human studies point to the 
key role of one oral pathogen, C. rectus, in mediating fetal exposure and morbidity. The 
advantage of the use of only one strain of bacteria is that it permits good control of the dose 
and timing of the infection, which is important to understand the virulence of the bacteria and 
maybe their mechanisms of action. 
In previous chamber studies in mice, infection with P. gingivalis A7436, that is a 
relatively virulent strain for this model, required pre-treatment of the mice with heat-killed 
organisms to elicit a protective antibody response to prevent the animal from sepsis or death 
following challenge with live bacteria. However, pilot ascending dosage studies with C. 
rectus strain 314 showed that this organism was well tolerated by the animals and pre-
treatment was not needed. This was consistent also with previous experiments where similar 
doses of a different strain of C. rectus (ATCC 33238) were used. 
In the current study, mice were infected with bacteria after they became pregnant, at 
E7.5. Although there are no data to support that C. rectus infection may reduce the fertility of 
the mice, we chose to challenge the dams after the early events of implantation that are 
critical for embryonic survival, but prior to the completion of placental development. The 
time of sacrifice, E16.5, coincided with the time by which the placenta stops growing, 
although some structural changes still occur within the organ.    
At the time of sacrifice bacteria were still present and alive in the subcutaneous 
chamber (unpublished data). This was assessed by culturing live bacteria from the chambers 
and by verifying with nested PCR that they were C. rectus. These data indicate that C. rectus 
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can survive the immune response mounted by the host and elicit its pathogenic properties 
throughout the time of the experiments.  
As expected, infection with C. rectus strain 314 led to increase in resorptions and 
IUGR as demonstrated by the reduction in fetal weight and crown-rump length. The 
percentages of resorptions and of IUGR fetuses were very similar to those observed after 
infection with C. rectus strain ATCC 33238. This suggests that the two organisms may have 
similar virulence and maybe common virulent factors. Interestingly, from the Campylobacter 
species, mainly C. rectus and C. fetus have been shown to be associated with adverse 
pregnancy outcomes. These bacteria are also the only Campylobacter species known to share 
a common virulence factor, the S-layer. It is possible that the S-layer may play a significant 
role in these processes, but further in depth studies are necessary to confirm this observation.  
Although, not all litters from infected dams had IUGR fetuses (fetal weight: 2 SD 
below the mean for gestational age) there was a significant decrease in the weight of non-
IUGR fetuses in the challenged dams. This suggests that maternal infection affected most, if 
not all, of the fetuses, albeit in various degrees. Interestingly though, the IUGR observed at 
E16.5 was not translated to LBW, nor did it result in a significant increase of newborn deaths 
when dams were allowed to deliver. This finding was not anticipated considering that runted 
and abnormal offspring usually do not survive immediately postpartum. How the fetuses 
manage to “catch-up” in weight during the last 3-4 days of gestation remains unknown. 
Maybe alternative pathways that control nutrient supplies are activated and rescue the IUGR 
fetuses.  
However, the survival of these newborns is only temporary. In the first postnatal 
week there is an increase in deaths of pups derived from challenged dams. This could occur 
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mainly from two reasons: a) although the neonatal weight is similar in both groups, pups 
from infected dams may present abnormalities acquired in utero that do not allow for short-
term survival, and b) differences in fostering from infected dams my render the pups more 
susceptible to death. For example, infected dams may serve as a reservoir of infectious or 
inflammatory stress, or may have impaired lactation. This last one though, is the least likely, 
since pups from challenged dams gained more weight during the first postnatal week. This 
abnormal increase in weight however, implies a possible deregulation in the metabolism of 
these pups, which supports the theory of acquired abnormalities during gestation.  
In summary, maternal infection with C. rectus induces IUGR at E16.5, but does not 
lead to LBW. However, pups from challenged dams show an increased risk for perinatal 
mortality and maybe morbidity. Both these observations are common in humans with LBW. 
Whether other periodontal bacteria besides C. rectus can induce similar outcomes remains to 
be elucidated. 
It is well established that normal fetal growth depends upon the structural and 
functional integrity of the placenta. Since infection induced IUGR, we hypothesized that it 
also would lead to abnormal placental function/development. This could be the consequence 
of either a secondary infection of the placenta induced by bacteria disseminating from the 
chamber, or the result of a systemic inflammatory response elicited by the mice to control the 
infection in the chamber, or a combination of both. In previous experiments, P. gingivalis 
was shown, with PCR, to be able to disseminate from the chamber and was found in the 
placenta and other maternal organs such as the liver. In our experiments using nested PCR 
we demonstrated that C. rectus strain 314 also was present in the placenta of IUGR fetuses. 
These data are consistent with those from experiments where C. rectus strain ATCC 33238 
117
was used. Of course, the PCR data cannot be interpreted as presence of live bacteria in the 
placenta since the bacteria in the chamber could have been phagocytosed by host immune 
cells that circulated in the blood stream and just happened to be present in the placenta at the 
time of sacrifice. This would provide an easy explanation as to why not all placentas from 
IUGR fetuses are positive for C. rectus.
Similar experiments as those used to detect live bacteria in the chambers were 
employed to assess whether C. rectus is alive in the placenta and hence determine if they 
disseminated from the chamber. In brief, for these experiments placental tissues were placed 
in an enriched broth. Live bacteria from inside the placenta were expected to “escape” the 
degrading placenta seeking nutrients in the broth. Bacteria were then transferred from the 
broth to tissue culture plates where only live bacteria would grow. Finally, once colonies 
were formed, nested PCR would be performed to verify that the bacteria are C. rectus. From 
the preliminary experiments conducted, none of the placentas could be shown to possess live 
bacteria. However, by no means can these results be considered conclusive since, 
Campylobacters are known to be non-cultivable upon oxygen exposure or after they have 
invaded cells. Invasion studies that we performed showed clearly that C. rectus has the 
potential to invade non-phagocytic cells even at low concentrations (unpublished data). 
These results were in accordance with other studies that found C. rectus in cells of the buccal 
mucosa. It is very likely that C. rectus actually invades trophoblast cells in the placenta 
rendering this organism non-culturable. Also, maybe the low number of bacteria in the 
placenta may have made the PCR detection of C. rectus misleading.  
The presence of C. rectus in the placenta, as detected by nested PCR, is comparable, 
in a way, to the detection of fetal C. rectus-specific IgM antibodies in the cord blood cells of 
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mothers with periodontal disease. Since these antibodies are produced in the fetus and/or the 
placenta it is assumed that C. rectus and/or its virulent factors reach the placenta and, maybe, 
get access to the fetal circulation by passing the placental barrier. Although cells in general 
do not cross the placenta and all the exchange of nutrients and wastes between the mother 
and fetus is well controlled, it may be that the very small size of C. rectus enables this 
organism to diffuse across the placenta and enter into the fetal circulation. This idea of 
transplacental passage of C. rectus is further supported by our findings in fetal brains. At 
E16.5 nested PCR for C. rectus revealed positive signals in fetal brains of IUGR fetuses. 
These signals were similar in percentage to those found in the placenta (unpublished data). 
Moreover, preliminary experiments using immunohistochemistry to detect C. rectus revealed 
the presence of these bacteria in brains from pups derived from challenged dams 
(unpublished data). The bacteria had a rod like shape and appeared morphologically to be 
vital. These histological sections derived from 9 day-old pups and hence, if the bacteria were 
not introduced to the neonates by the dams during lactation, they should have entered the 
fetus in utero. Collectively these data imply that, although the placenta plays the role of an 
immunological barrier protecting the fetus from microorganisms, it is not able to sufficiently 
contain and eliminate C. rectus, which “trespasses” to the fetal circulation from where it may 
invade the brain and possibly other fetal organs.   
The presence of bacteria in fetal brain tissues was also associated with a local 
increase in the expression of inflammatory cytokines, such as Ifn-g and Tnf-L. Studies have 
shown that Ifn-g is a potent mediator of neuronal oxidative stress and can mediate neuronal 
apoptosis and impair myelination. Similarly, apoptosis of oligodendrocytes can be induced 
by Tnf-L. Hence, it would be expected, pups derived from infected dams to show impaired 
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neurological development. Indeed, in our infection model, caspase 1, a marker of apoptosis, 
was upregulated in the hippocampus region of brains of pups derived from challenged dams 
(unpublished data). Moreover, electron microscope experiments revealed myelination defects 
in the same region. It is obvious that the detailed understanding of these processes requires 
further investigation, but the data obtained so far suggest that maternal infection with C. 
rectus has consequences that are not only limited to the in utero growth, but extend also to 
the postnatal period.  The preliminary evidence of perinatal neurological impairment may be 
only one of the many abnormalities that the newborns may demonstrate, and may explain in 
part the observed increase in perinatal deaths. As mentioned earlier, pups that survive the 
first week demonstrate also abnormal gain of weight suggesting possible metabolic 
deregulation. It may be, that survivors are pups that are not affected by the maternal infection 
or pups that present the least abnormalities that allows them to escape early death. 
Interestingly, preliminary experiments with adult mice that “made it” through the perinatal 
period showed they performed worse in several behavioral tests (unpublished data). Hence, it 
is very likely that the neurological and other possible abnormalities may persist in various 
degrees throughout the life of the mice and affect different aspects of their survival. If this is 
true it would seem consistent with findings in humans where impaired intrauterine growth is 
associated with increased perinatal mortality and long-term morbidity. 
The observed IUGR and the bacterial spread to the fetus suggest that the placenta is 
not able to adequately perform some of its basic roles. Since the function of this organ 
mainly depends upon its normal growth and development it seemed reasonable to believe 
that the maternal infection could impair these processes. The normal size/weight of the 
placenta is considered critical for the adequate exchange of nutrients and wastes between the 
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mother and the fetus. Hence, in most animal models the fetal weight correlates with the 
placental weight, and thus IUGR is commonly associated with a decrease in the size/weight 
of the placenta. However, quite surprisingly, in our model the placenta that corresponded to 
IUGR fetuses were not statistically different in weight from those corresponding to normal 
weight fetuses. This finding cannot be explained based on the general rule described above 
and implies that the deficiency of the placenta may lie in the interior structure of this organ. 
Indeed, our results clearly demonstrate that maternal infection with C. rectus induced 
significant structural alterations in the layers that constitute the placenta. In placenta of IUGR 
fetuses there was a relative decrease of the labyrinth with a concomitant relative increase of 
the decidual layer. The spongiotrophoblast layer was the least affected, and as far as the giant 
cells, our findings could provide very little information, since these cells form a monolayer 
which is often hard to trace throughout the histological sections. Although, as mentioned 
previously, the weight of the placenta was not altered between the challenged and control 
dams, the histological presentation of the placenta with a relatively small labyrinth is very 
typical of placenta that correspond to IUGR fetuses. The decreased thickness of the labyrinth 
zone suggests that there may be impaired vascularization of the placenta. This architectural 
abnormality has often been interpreted as indicative of potential impairment in placentation 
and nutrient flow to the fetus since, in mice, the exchange of respiratory gases, nutrients, and 
wastes takes place in the labyrinth.  
Why the decidua and the labyrinth of placenta from IUGR fetuses show these 
remarkable structural alterations is not fully understood. In general, the fetal layers come in 
contact with the uterus via the maternally derived decidua. In early stages of placental 
development the decidua is bigger in size than the placenta, but as the placenta grows the 
121
decidua decreases in size. Specifically, as the labyrinth expands, to accommodate the 
increased demand of nutrients for the growing fetus, the spongiotrophoblast and giant cells 
that support the labyrinth, invade further into the decidua. Based on this knowledge, several 
hypotheses may explain the placental abnormalities observed. It is possible that the maternal 
infection affects the function of the spongiotrophoblast and giant cells and renders them less 
effective in invading the uterus. Thus, although the labyrinth may have the potential to 
expand it may be restrained by its supporting layers. However, mutant mice that do not 
express genes involved in the development and function of these cells types show defects in 
these layers that are not present in our model. Of course, it has to be kept in mind that, 
although some similarities between the placental phenotypes of IUGR fetuses from our 
infection model and from knockout mice may be present, the degree of similarity could vary 
since the two models have substantial differences. Another reason why the 
spongiotrophoblast and giant cells may not be effective in invading the uterus may be the 
presence of extensive edema observed in the decidua of several IUGR placenta. This increase 
in edema formation may disorganize the tissues and prevent normal invasion of giant cells in 
the uterus. The fact that the edema is located mainly in the decidua is consistent with the 
increased presence of an inflammatory infiltrate in the spongiotrophoblasts and the decidua. 
It is thought that the trophoblasts act as a pregnancy-specific component of the innate 
immune system that combats placental challenges from pathogens. Hence, although it is 
expected to find some extent of inflammatory infiltrate in the maternal-fetal interface in all 
placenta, an increased inflammatory infiltrate may suggest a more severe bacterial challenge 
of the placenta. It is likely, that the placenta of IUGR fetuses are challenged by C. rectus, that 
disseminate from the chamber, and organize an inflammatory response. This would be 
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consistent with previous reports that demonstrate an augmented proinflammatory cytokine 
response in placenta of P. gingivalis challenged dams. Moreover, it is known that human 
trophoblast cells not only express TLR4, a cellular receptor that recognizes the basic 
component of the outer membrane of Gram negative bacteria (lipopolysaccharides), but also 
induce in vitro proinflammatory cytokine production after ligation with LPS (8). Hence, 
maternal infection may elicit an immunological response in the placenta that may alter its 
structure and therefore affect normal fetal growth.  
Finally, another reason why the decidua and labyrinth of placenta from IUGR fetuses 
show structural abnormalities may be that maternal infection impairs the ability of the 
labyrinth to develop an extensive villous branching. Hence, the labyrinth remains small in 
size and the spongiotrophoblast and giant cells that support the labyrinth and follow its 
growth do not invade deeper into the uterus. 
To better understand the structural alterations of the placenta that are associated with 
IUGR, we used microarray technology to examine the possible effects of maternal infection 
in the development and growth of the different placental layers. This approach has proven to 
be a useful tool for gene expression profiling and has been used in similar experiments by 
several investigators (9). A major disadvantage of this technique is that it is semi-
quantitative, so the expression of the genes of interest has to be further verified by more 
accurate techniques, such as quantitative PCR. However, this technology offers the 
advantage of analyzing the expression of thousands of genes simultaneously. Moreover, the 
available software technology can cluster genes with similar patterns of expression and 
identify common pathways that are activated, allowing for a broader perspective of the 
biology that governs the tissue under examination.  
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Based on the analysis of the array data, we found that the expression of only 74 genes 
was statistically different in the placenta of IUGR fetuses compared to those of normal and 
unchallenged fetuses. The relatively low number of genes that were differentially expressed 
can be attributed to the very stringent parameters used in our analysis in order to gain more 
reliable results. Specifically, we analyzed the data using the permutation test at a false 
positive discovery rate (FDR) of less than 0.05, when it is common to use a FDR ranging 
from 0.05 to 0.125. Moreover, in order for each gene to be included in the statistical analysis, 
only the data from one array per group could be “flagged”. Hence, the analysis used data 
from a minimum of 5 out of the 7 arrays (3 control and 4 challenged). 
From the 74 differentially expressed genes 9 were upregulated while the rest were 
downregulated indicating, that the effects of maternal infection on gene expression were 
predominantly suppressive rather than stimulatory. Most of these genes were related with 
hypothetical proteins, RIKEN cDNA sequences, different clone images and other proteins 
with no specific or known function. However, there were also some genes of known 
function, but only a few had an obvious role in placental development and growth.  
From the 9 genes that were upregulated most of them were involved in the supply of 
oxygen to the fetus and the development of the vascular system. Specifically, the embryonic 
hemoglobins Z and Y are known to be produced by the yolk sac and the embryo and are 
critical for the transport of oxygen towards the fetus via the blood circulation. The finding 
that these hemoglobins are upregulated in our arrays, suggests that these proteins may also be 
produced in the mouse placenta. The impaired transfer of nutrients such as oxygen, due to the 
small size of the labyrinth, may have stimulated the placenta to increase its efficiency by 
producing more molecules that enhance this process. Two other genes that were also 
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upregulated included genes that encode prolactin-like protein B (Prlpb) and glypican 1 
(Gpc1). Prlpb is related to prolactins that are expressed in the placenta and uterus. In general, 
prolactins have important modulatory actions during the establishment of pregnancy and the 
initiation of parturition and they consist of three groups of proteins: the placental lactogens, 
the prolactins involved in parturition, and the proliferins. No specific function has been 
attributed to Prlpb, but since it belongs to the proliferins it is thought that it modulates blood 
vessel development (10). Gcp1 is a proteoglycan expressed in the placenta. It regulates the 
function of FGF by binding to this growth factor, and it acts as a chaperon for various VEGF 
molecules. Hence, Gcp1 is thought to be involved in growth and differentiation and 
especially in angiogenesis (11). The increase in expression of Prlpb and Gcp1 may indicate 
that the placenta of IUGR fetuses are trying to restore the defective labyrinth and enhance its 
vascularization. The extension of vascular branching will increase the surface where nutrients 
are exchanged and therefore the amount of nutrients transferred to the fetus. For the already 
growth restricted fetuses this placental response may be very critical, especially considering 
that a significant portion of fetal growth is yet to come.  
Surprisingly, none of the 9 genes that were upregulated included genes that encode 
inflammatory mediators. This result was not anticipated considering the increase of 
inflammatory infiltrate observed in the histological sections. Moreover, in previous reports 
where dams were challenged with P. gingivalis, there was an increase in the expression of 
proinflammatory Th1 type cytokines and of Tnf- in placentas of IUGR fetuses. It is 
possible, that the majority of the innate inflammatory response against C. rectus took place at 
an earlier stage before E16.5 and now this response has subsided and is not detected with the 
microarray data analysis. It is also likely that the technique used is not able to detect a 
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statistical difference in the expression in these genes even though that difference is actually 
present. 
Genes that were downregulated and had known functions, could generally be 
separated into two groups based on their biological actions: a) genes that mainly affect the 
development of the fetus, and b) genes that mainly affect the development of the placenta. 
The first group included the majority of genes, however, their possible role in placental 
development has not been studied and therefore should not be excluded. 
Specifically, genes in this group include genes that encode the DNA binding protein 
Desrt, the type VIIa1 collagen, the olfactory receptors MOR 31-3 and MOR 256-3, the 
synaptotagmin X (Syt10), and the neuropeptide galanin (Gal) and its receptor (Galr3). Desrt 
is important for growth and normal development of the reproductive organs.  Knockout mice 
that do not express this gene have reduced viability, pronounced growth retardation, and a 
high incidence of abnormalities of the female and male reproductive organs (12). Collagen 
VIIa1 is the main collagen type present in the skin and mutation of this gene leads to skin 
disorders (dystrophic epidermolysis bullosa) in humans (13). The olfactory receptors are 
important for the olfactory function and this is impaired or even lost with the reduction of 
these receptors (14). Interestingly, in mice, the olfactory system has been shown to be critical 
for mate recognition and sexual behavior in females (15). Syt10 regulates the secretion of 
neurotransmitters stored in the synaptic vesicles and thus affects the signaling between 
neurons (16). Impairment of the nervous system is also found in mutants that do not express 
galanin. Galanin is a neuropeptide, and mice lacking this peptide show lower numbers of 
sensory neurons and reduced capability for nerve regeneration (17) Moreover, galanin and its 
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receptor are considered to have functions related to energy and nutrient balance, since 
administration of galanin to experimental animals stimulates food intake (18).  
From all the above, it is clear that these genes are involved in the normal development 
and function of a variety of adult tissues. However, it is not known whether the observed 
downregulation of these genes in the placenta can have a direct effect on the developing 
fetus. It is likely, that during gestation the immature fetal tissues may not be able to produce 
sufficient amounts of all proteins related to development, and thus rely on the placenta for 
their supplementation. In this case, downregulation of such genes in the placenta may be 
critical for the developing fetus and may contribute to anomalies found in the offspring later 
in life.  
 From the genes that were downregulated only two could be related to the 
development of the placenta and included the reticulon 4 receptor (Rtn4r) and the placental 
growth factor (Pgf). Rtn4r is the receptor of reciculon, also known as neuroendocrine-
specific protein. Its function is currently unknown, but it is thought to be associated with 
transport processes in the endoplasmic reticulum (ER). Although, the importance of Rtn4r in 
these processes remains to be elucidated, it is well established that, at a cellular level, the ER 
is important for the secretion of proteins. Hence, even though the reduction of Rtn4r may not 
directly affect a distinct placental function, it may compromise the normal function of cells 
within the placenta.  
A more specific effect on placental development may be associated with the 
downregulation of Pgf. The growth factor encoded by this gene belongs to the VEGF family 
of proteins and is expressed only in placental tissues. It is an important angiogenic factor that 
along with the other VEGFs regulates vascularization and vascular permeability, while it is 
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thought to participate also in the regulation of the vascular tone and blood flow (19).  Mice 
that do not express Pgf show impaired angiogenesis, and in humans, downregulation of Pgf is 
associated with pregnancy complications such as preeclampsia. Also, cross-sectional studies 
in normal pregnancies indicate that Pgf levels rise during the second trimester and peak at the 
early third trimester (20). If similar events are true in mice, the observed downregulation of 
Pgf may explain in part the deficiency in the growing labyrinth. In fact, this is the first report 
that demonstrates that growth factors important for the growth and development of the 
placenta are downregulated due to maternal infection with bacteria. 
Several other proteins, such as different kinases were also downregulated. Since these 
kinases are considered to participate in a variety of signaling pathways we were not able to 
associate them with a specific function and hence could not assign them to either of the two 
groups described. 
Although, as mentioned earlier, these two groups were determined based on the 
biological functions of the genes, further microarray data analysis could not identify specific 
pathways that were either upregulated or downregulated within these groups. It is very likely, 
that although some signaling pathways are differentially activated, the small number of genes 
involved in this analysis made these pathways non-detectable. 
A different approach to cluster genes that are possibly involved in common signaling 
pathways is by using the K-Means algorithm (21). This algorithm clusters genes not based on 
their biological functions, but based on similar gene expression profiles. The assumption 
behind this analysis is that genes with similar expression patterns may participate in common 
or related signaling pathways. From the 5 clusters generated, all genes that were upregulated 
and involved in nutrient supply and blood vessel development were found in the same 
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cluster. From the genes that were downregulated and thought to be involved in fetal 
development all except for galanin and its receptor were in the same cluster, different though 
from that of the upregulated genes. Finally, in a third cluster of genes we could identify the 
genes that are considered important for placental development. In this cluster galanin and its 
receptor were also included. All other genes, mainly of unknown function, were found 
throughout the 5 clusters. The fact, that this clustering method grouped the genes in a similar 
fashion as we had grouped them based on their biological functions may imply a common 
regulation of these genes. Although the genes involved in fetal development may not be 
obviously related, since they affect different types of tissues, it is possible that they may have 
a common upstream control. 
Besides the useful information that can be extracted using the various data analysis 
software, valuable insight about the effects of maternal infection in placental development 
can also be generated by studying the microarray raw data. This approach revealed a 
differential expression of several inflammatory mediators. Some genes responsible for 
proinflammatory molecules such as Il-1 and S100a and S100b were upregulated, while others 
such as Tnf-L was slightly downregulated. From the genes encoding Th1 and Th2 type of 
inflammatory cytokines Ifn-g and Il-4 were upregulated, while Il-2 and Il-10 were 
downregulated. Hence, although previous studies with P. gingivalis report a shift in the 
placental Th1/Th2 cytokine balance towards a Th1 response, our data were not able to clearly 
support a similar shift. 
On the contrary, when genes important for placental/fetal growth and development 
were evaluated, there was a very clear pattern of expression with the majority of the genes 
downregulated to various degrees. Moreover, when genes essential for placental 
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development, as determined with knockout mouse models, were evaluated as a cluster, there 
was a significant depression in the expression of the group that exceeded 50%. Since none of 
these genes is extremely suppressed in our infection model, it is normal to expect that the 
histological presentation of placenta of IUGR fetuses will not match exactly with that of 
placenta from knockout mice. However, the decrease in the expression of multiple growth-
related genes may act synergistically to impair placental development, as noted with the 
smaller labyrinth. In addition, if growth factors produced in the placenta are shared also by 
the fetus, a shortage of these factors, due to maternal infection, may contribute to possible 
abnormalities in the offspring. This would further support the notion that the in utero 
environment is critical for the future well being of the individual. 
Another important information revealed from the microarrays is the effect of maternal 
infection on imprinted genes. The majority of these genes are involved in growth and 
development. In general, these genes are expressed only from one of the parental alleles, 
while the other allele is silenced due to a methylation pattern that is imprinted on the DNA. 
The regulation of growth factor expression by imprinting is considered to allow for the 
control of resource allocation. Most of the imprinted genes are expressed in the placenta and 
some of them have been identified, directly or indirectly, to be critical for placental/fetal 
growth and transplacental nutrient transport. As shown in Table 4.1, the microarray data 
demonstrate that the bulk of these imprinted genes is downregulated in placenta from IUGR 
fetuses. Interestingly, in humans, downregulation of several imprinted genes is also observed 
in placenta of term IUGR fetuses (9). The downreglation of imprinted genes may imply that 
maternal insult with bacteria may alter the expression of these genes possibly by affecting 
their imprinting mechanism. This idea is also strengthened by the observation that the 
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expression of the gene for cytosine DNA methyltransferase is increased, suggestive of an 
enhanced DNA methylation activity. Several environmental factors such as diet, have been 
associated with epigenetic modification of methylation patterns, but it is the first time that a 
bacterial infection was shown to affect the expression of imprinted genes.  
To further investigate the effect of infection on imprinting we focused on one gene, 
Igf2, that is known to be important for placental and fetal growth. Even though, the array data 
analysis only indicated that the expression of this gene was decreased, real time PCR 
revealed that, in fact, this depression was also statistically significant. Although both 
techniques led to similar quantitative results the difference in the statistical analysis may be 
attributed to the larger sample size used with the PCR method. 
To verify that the maternal infection may alter the methylation patterns of the Igf2 
gene we used the sodium bisulfite modification and sequencing technique. Based on this 
technique DNA is treated with sodium bisulfite and cytosine bases that are not methylated 
are converted to uracil, while the methylated cytosine bases are protected and remain 
unchanged. The change in the DNA sequence depending upon the methylation status of the 
cytosines can then be detected by DNA sequencing. This method offers the advantage of 
obtaining accurate results by “reading” sequences. Moreover, it can evaluate at the same time 
whether the conversion of the bases is complete or whether some areas were deprived of the 
bisulfite treatment, due to structural features of the DNA. However a disadvantage of this 
technique lies on the fact that, unless there is a known mutation on one of the parental alleles 
it is impossible to distinguish the parental origin of the DNA sequenced. In order to 
compensate for this parent of origin bias we increased the number of clones examined to 50-
90, when usually 10-20 clones are considered sufficient. 
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Since the exact methylation pattern of the Igf2 gene in the placenta in not defined we 
selected to determine changes in methylation in the promoter region that is activated in the 
placenta (P0). This promoter has been shown to be very critical for placental development. 
Disruption of the placenta-specific Igf2is associated with fetal and placental growth 
restriction. Similarly to our infection model where Igf2 is decreased, the labyrinth of these 
placenta is reduced in size and there is a reduction in the expression of specific nutrient 
transporters. However, the P0 deficient placentas also show a reduction in glycogen cells and 
glycogen content, that was not statistically altered in our model (unpublished data). It is 
possible, that the small sample size and the lack of specificity of the PAS staining used to 
stain glycogen may have contributed to these results.  
Besides the fact that the P0 is important for the expression of Igf2 in the placenta, 
several other key factors related to methylation were taken under consideration to choose this 
region for these studies: a) The insulation area between Igf2 and H19, although important for 
Igf2 imprinting, has been demonstrated to be tissue specific. To date, no information about its 
role in placental tissues is available. b) This region of the DNA is part of a differentially 
methylated region (DMR0), and DMRs are known to be involved in imprinting processes. c) 
The P0 is rich in CpG sequences, which are potential sites for methylation. d) The P0 
contains a CTCF binding motif that is critical for the function of the insulation area between 
Igf2 and H19, but has not been studied in the placenta. 
The results from these experiments, clearly demonstrate that there is a change in the 
methylation pattern of the P0 region and specifically hypermethylation. Although there was 
an overall increase in methylation throughout the entire region, it was only significant in 
some CpGs indicating that the methylation may be site directed. It is known, that not all CpG 
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sites are of equal importance when it comes to imprinting, so whether the specific sites that 
were methylated are critical for imprinting remains to be answered. However, some of the 
hypermethylated CpG sites appear to be part of DNA sequences that are recognized by 
specific transcription elements, but it is unclear how these transcription factors may affect 
Igf2 transcription. Finally, some CpG sites were found not to be completely unmethylated. 
The importance of this is unknown, but it is likely that the DNA conformation in that region 
is such, that it does not allow the binding of methyltransferases and consequent addition of 
methyl-groups. 
It is important to note at this point, that these experiments solely show the changes in 
methylation patterns in the P0 region and do not associate the observed hypermethylation 
with the decreased Igf2 gene expression. However, since, promoter hypermethylation has 
been associated with gene silencing, it is possible that the increase in methylation in the P0 
promoter may have contributed to the decreased expression of Igf2 in the placenta. Maybe 
future experiments using 5-Azacytidine, a compound that inhibits DNA methylation, may 
provide further insight in this matter. It is clear also, that these findings do not exclude the 
possibility that other pathways may decrease the expression of Igf2 too.  
Whether alterations in methylation patterns occur only in Igf2 is currently unknown. 
Yet, the consistent decrease in expression of many imprinted genes suggests that other 
imprinted genes may also be affected. Moreover, it remains to be elucidated whether 
hypermethylation is induced directly by the bacteria or indirectly by the inflammatory 
mediators elicited by the host against these bacteria. Finally, it is not clear whether promoter 
hypermethylation can take place in the fetal tissues too. The fact though, that C. rectus is 
present in fetal brain tissues increases the chances that this may actually be true.  
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In this case, maternal infection may have far-reaching effects by modifying directly 
the well being of the offspring. Methylation patterns are inherited by somatic cells and any 
epigenetic modification in these patterns is usually preserved throughout the lifetime of the 
individual. Hence, changes in methylation that occurred in utero due to maternal infections 
could be maintained through adulthood. Currently, imprinted genes are starting to be 
implicated with several disorders, such as schizophrenia, asthma, and metabolic diseases like 
Type 2 diabetes. These and other disabilities are also associated with extremely LBW. It is 
very likely that intrauterine infection may not only affect fetal growth, but in addition initiate 
a somatically inherited condition, that may permanently alter the phenotype of the off-spring. 
In conclusion, in this study we have shown that maternal infection with C. rectus 
induces IUGR at E16.5 and an increase in the mortality and morbidity of pups in the first 
postnatal week. The deficient fetal growth is probably the result of an impaired development 
of the placenta, as demonstrated by the structural abnormalities present such as the small size 
of the labyrinth. These placental alterations may have occurred due to dissemination of 
bacteria in the placenta as detected by nested PCR and the increase in the inflammatory 
infiltrate. Bacteria were also present in fetal brain tissues implying that there is transplacental 
passage of bacteria to the fetus. The presence of bacteria in the brain was evident also in 9 
day-old pups and was associated with ultrastructural alterations in these tissues. The deficient 
growth of the placenta was accompanied by a decrease in the expression of genes associated 
with the growth and development of the placenta and the fetus. Among these genes there 
were several imprinted genes, like Igf2. Maternal infection with C. rectus led to 
hypermethylation of the placental-specific Igf2 promoter, which may explain in part the 
decrease in the expression of this gene. Since epigenetic modifications of imprinted genes are 
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inherited by somatic cells, there is a possibility that in utero infections may alter the 
expression patterns of these genes permanently. The association of imprinted genes in several 
disorders may imply that maternal infections may have effects beyond the placenta affecting 
the well being of the individual.     
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Figure 4.1. Comparative placental structures between mice and humans. Figure adapted 
from reference 1.  
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Table 4.1. Differential expression of imprinted genes in the placenta after maternal infection 
with C. rectus. This table includes only the genes known to be important for placental/fetal 
growth and development.  
 
Gene 
Fold 
Decrease 
Dio3 3.29 
Slc38a4 2.18 
Mash2 1.96 
Igf2 1.92 
Meg3 1.91 
Cdkn1c 1.65 
Slc22a3 1.56 
Peg3 1.44 
H19 liver 1.43 
Gatm 1.37 
Grb10 1.35 
Usp29 1.31 
Nap1/4 1.23 
Slc221l 1.23 
Obph1 1.19 
Zim1 1.17 
Dlk1 1.10 
Tssc4 1.09 
Ins2 1.02 
U2af1-rs1 1.01 
Impact 0.98 
Copg2 0.79 
Slc22a2 0.74 
Murr1 0.74 
Meg1 0.66 
H19 clone 0.51 
137
References 
 
1. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev 
Genet. 2001;2:538-48. 
 
2.  Alders M, et al. The human Achaete-Scute homologue 2 (ASCL2, HASH2) maps to 
chromosome 11p15. 5, close to IGF2 and is expressed in extravillus trophoblasts. Hum. 
Mol. Genet. 1997;6:859-867. 
 
3.  Janatpour M.J. et al. A repertoire of differentially expressed transcription factors that 
offers insight into mechanisms of human cytotrophoblast differentiation. Dev. Genet. 
1999;25:146-157. 
 
4.  Knofler M., Meinhardt G., Vasicek R., Husslein P. & Egarter C. Molecular cloning of 
the human Hand1 gene/cDNA and its tissue-restricted expression in cytotrophoblastic 
cells and heart. Gene. 1998;224:77-86. 
 
5. Nait-Oumesmar B., Copperman A. B. & Lazzarini, R. A. Placental expression and 
chromosomal localization of the human Gcm 1 gene. J. Histochem. Cytochem. 
2000;48:915-922. 
 
6.  Somerset D.A, et al. Ontogeny of hepatocyte growth factor (HGF) and its receptor (c-
met) in human placenta: reduced HGF expression in intrauterine growth restriction. Am. 
J. Pathol. 1998;153:1139-1147. 
 
7.  Krebs C, et al. Intrauterine growth restriction with absent end-diastolic flow velocity in 
the umbilical artery is associated with maldevelopment of the placental terminal villous 
tree. Am. J. Obstet. Gynecol. 1996;175:1534-1542. 
 
8.  Holmlund U, et al. Expression and regulation of the pattern recognition receptors Toll-
like receptor-2 and Toll-like receptor-4 in the human placenta. Immunology.
2002;107:145-51. 
 
9.  McMinn J, et al. Unbalanced Placental Expression of Imprinted Genes in Human 
Intrauterine Growth Restriction. Placenta. Online 2005. 
 
10.  Muller H, Ishimura R, Orwig KE, Liu B, Soares MJ. Homologues for prolactin-like 
proteins A and B are present in the mouse. Biol Reprod. 1998;58:45-51. 
 
11.  Gengrinovitch S, et al. Glypican-1 is a VEGF165 binding proteoglycan that acts as an 
extracellular chaperone for VEGF165. J Biol Chem. 1999;274:10816-22. 
 
12.  Lahoud MH, et al. Gene targeting of Desrt, a novel ARID class DNA-binding protein, 
causes growth retardation and abnormal development of reproductive organs. Genome 
Res. 2001;11:1327-34. 
 
138
 
13.  Kern JS, Kohlhase J, Bruckner-Tuderman L, Has C. Expanding the COL7A1 Mutation 
Database: Novel and Recurrent Mutations and Unusual Genotype - Phenotype 
Constellations in 41 Patients with Dystrophic Epidermolysis Bullosa. J Invest Dermatol 
advance online publication 16 February 2006; doi: 10.1038/sj.jid.5700219 
 
14.  Rawson NE. Olfactory loss in aging. Sci Aging Knowledge Environ. Online 2006. 
 
15.  Keller M, Douhard Q, Baum MJ, Bakker J. Destruction of the Main Olfactory 
Epithelium Reduces Female Sexual Behavior and Olfactory Investigation in Female 
Mice. Chem Senses. Online 2006. 
 
16.  Chapman ER, et al. Fatty acylation of synaptotagmin in PC12 cells and synaptosomes. 
Biochem Biophys Res Commun. 1996;225(1):326-32. 
 
17.  Holmes FE, et al. Targeted disruption of the galanin gene reduces the number of 
sensory neurons and their regenerative capacity. Proc Natl Acad Sci U S A.
2000;97:11563-8. 
 
18.  Kyrkouli SE, Stanley BG, Seirafi RD, Leibowitz SF. Stimulation of feeding by galanin: 
anatomical location and behavioral specificity of this peptide’s effects in the brain. 
Peptides. 1990;11:995–1001 
 
19.  Yang W, Ahn H, Hinrichs M, Torry RJ, Torry DS. Expression and function of placenta 
growth factor: implications for abnormal placentation. J Soc Gynecol Investig..
2003;10:178-88. 
 
20.  Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ. Preeclampsia is associated with 
reduced serum levels of placenta growth factor. Am J Obstet Gynecol. 1998;179:1539-
44. 
 
21.  Dov Stekel. Microarray Bioinformatics. Cambridge University Press. 2003 
